
<html lang="en"     class="pb-page"  data-request-id="8c682696-2217-4c83-ad9d-78496076f9da"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm051106d;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2006.49.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Preclinical Studies of (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor" /></meta><meta name="dc.Creator" content="Rajeev S.  Bhide,*" /></meta><meta name="dc.Creator" content="Zhen-Wei  Cai," /></meta><meta name="dc.Creator" content="Yong-Zheng  Zhang," /></meta><meta name="dc.Creator" content="Ligang  Qian," /></meta><meta name="dc.Creator" content="Donna  Wei," /></meta><meta name="dc.Creator" content="Stephanie  Barbosa," /></meta><meta name="dc.Creator" content="Louis J.  Lombardo," /></meta><meta name="dc.Creator" content="Robert M.  Borzilleri," /></meta><meta name="dc.Creator" content="Xiaoping  Zheng," /></meta><meta name="dc.Creator" content="Laurence I.  Wu," /></meta><meta name="dc.Creator" content="Joel C.  Barrish," /></meta><meta name="dc.Creator" content="Soong-Hoon  Kim," /></meta><meta name="dc.Creator" content="Kenneth  Leavitt," /></meta><meta name="dc.Creator" content="Arvind  Mathur," /></meta><meta name="dc.Creator" content="Leslie  Leith," /></meta><meta name="dc.Creator" content="Sam  Chao," /></meta><meta name="dc.Creator" content="Barri  Wautlet," /></meta><meta name="dc.Creator" content="Steven  Mortillo," /></meta><meta name="dc.Creator" content="Robert  Jeyaseelan Sr.," /></meta><meta name="dc.Creator" content="Daniel  Kukral," /></meta><meta name="dc.Creator" content="John T.  Hunt," /></meta><meta name="dc.Creator" content="Amrita  Kamath," /></meta><meta name="dc.Creator" content="Aberra  Fura," /></meta><meta name="dc.Creator" content="Viral  Vyas," /></meta><meta name="dc.Creator" content="Punit  Marathe," /></meta><meta name="dc.Creator" content="Celia  D'Arienzo," /></meta><meta name="dc.Creator" content="George  Derbin, and" /></meta><meta name="dc.Creator" content="Joseph  Fargnoli" /></meta><meta name="dc.Description" content="A series of substituted 4-(4-fluoro-1H-indol-5-yloxy)pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of vascular endothelial growth factor receptor-2 kinase is reported. Structure−activity relations..." /></meta><meta name="Description" content="A series of substituted 4-(4-fluoro-1H-indol-5-yloxy)pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of vascular endothelial growth factor receptor-2 kinase is reported. Structure−activity relations..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="March 16, 2006" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm051106d" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-49-7-2143" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(05)01106-4" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2006 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm051106d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm051106d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm051106d" /></link>
        
    
    

<title>Discovery and Preclinical Studies of (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm051106d" /></meta><meta property="og:title" content="Discovery and Preclinical Studies of (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106dn00001.jpeg" /></meta><meta property="og:description" content=" A series of substituted 4-(4-fluoro-1H-indol-5-yloxy)pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of vascular endothelial growth factor receptor-2 kinase is reported. Structure−activity relationship studies revealed that a methyl group at the 5-position and a substituted alkoxy group at the 6-position of the pyrrolo[2,1-f][1,2,4]triazine core gave potent compounds. Biochemical potency, kinase selectivity, and pharmacokinetics of the series were optimized and in vitro safety liabilities were minimized to afford BMS-540215 (12), which demonstrated robust preclinical in vivo activity in human tumor xenograft models. The l-alanine prodrug of 12, BMS-582664 (21), is currently under evaluation in clinical trials for the treatment of solid tumors.  " /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content=" A series of substituted 4-(4-fluoro-1H-indol-5-yloxy)pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of vascular endothelial growth factor receptor-2 kinase is reported. Structure−activity relationship studies revealed that a methyl group at the 5-position and a substituted alkoxy group at the 6-position of the pyrrolo[2,1-f][1,2,4]triazine core gave potent compounds. Biochemical potency, kinase selectivity, and pharmacokinetics of the series were optimized and in vitro safety liabilities were minimized to afford BMS-540215 (12), which demonstrated robust preclinical in vivo activity in human tumor xenograft models. The l-alanine prodrug of 12, BMS-582664 (21), is currently under evaluation in clinical trials for the treatment of solid tumors.  " /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106dn00001.jpeg" /></meta><meta name="twitter:title" content="Discovery and Preclinical Studies of (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm051106d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm051106d">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm051106d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm051106d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm051106d&amp;href=/doi/10.1021/jm051106d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2006</span><span class="cit-fg-volume">, 49</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2143-2146</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/49/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Letter</span><a href="/doi/10.1021/jm060036n" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Preclinical Studies of (<i>R</i>)-1-(4-(4-Fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5- methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajeev+S.++Bhide">Rajeev S. Bhide</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhen-Wei++Cai">Zhen-Wei Cai</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong-Zheng++Zhang">Yong-Zheng Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ligang++Qian">Ligang Qian</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donna++Wei">Donna Wei</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie++Barbosa">Stephanie Barbosa</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louis+J.++Lombardo">Louis J. Lombardo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+M.++Borzilleri">Robert M. Borzilleri</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoping++Zheng">Xiaoping Zheng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurence+I.++Wu">Laurence I. Wu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+C.++Barrish">Joel C. Barrish</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Soong-Hoon++Kim">Soong-Hoon Kim</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth++Leavitt">Kenneth Leavitt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arvind++Mathur">Arvind Mathur</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leslie++Leith">Leslie Leith</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sam++Chao">Sam Chao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barri++Wautlet">Barri Wautlet</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Mortillo">Steven Mortillo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Jeyaseelan">Robert Jeyaseelan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Kukral">Daniel Kukral</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+T.++Hunt">John T. Hunt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amrita++Kamath">Amrita Kamath</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aberra++Fura">Aberra Fura</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Viral++Vyas">Viral Vyas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Punit++Marathe">Punit Marathe</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celia++D%27Arienzo">Celia D'Arienzo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George++Derbin">George Derbin</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Fargnoli">Joseph Fargnoli</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm051106d&amp;href=/doi/10.1021%2Fjm051106d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2006</span></span><span class="cit-volume">, 49</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2143–2146</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 16, 2006</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 November 2005</li><li><span class="item_label"><b>Published</b> online</span>16 March 2006</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 April 2006</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm051106d" title="DOI URL">https://doi.org/10.1021/jm051106d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2006 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2143%26pageCount%3D4%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRajeev%2BS.%2BBhide%252C%2BZhen-Wei%2BCai%252C%2BYong-Zheng%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D49%26issueNum%3D7%26contentID%3Djm051106d%26title%3DDiscovery%2Band%2BPreclinical%2BStudies%2Bof%2B%2528R%2529-1-%25284-%25284-Fluoro-2-methyl-1H-indol-5-yloxy%2529-5-%2Bmethylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propan-%2B2-ol%2B%2528BMS-540215%2529%252C%2Ban%2BIn%2BVivo%2BActive%2BPotent%2BVEGFR-2%2BInhibitor%26numPages%3D4%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2146%26publicationDate%3DApril%2B2006">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm051106d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2480</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">96</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm051106d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Preclinical Studies of (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rajeev&quot;,&quot;last_name&quot;:&quot;S. Bhide&quot;},{&quot;first_name&quot;:&quot;Zhen-Wei&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;Yong-Zheng&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Ligang&quot;,&quot;last_name&quot;:&quot;Qian&quot;},{&quot;first_name&quot;:&quot;Donna&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;Barbosa&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;J. Lombardo&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;M. Borzilleri&quot;},{&quot;first_name&quot;:&quot;Xiaoping&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Laurence&quot;,&quot;last_name&quot;:&quot;I. Wu&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;C. Barrish&quot;},{&quot;first_name&quot;:&quot;Soong-Hoon&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;Leavitt&quot;},{&quot;first_name&quot;:&quot;Arvind&quot;,&quot;last_name&quot;:&quot;Mathur&quot;},{&quot;first_name&quot;:&quot;Leslie&quot;,&quot;last_name&quot;:&quot;Leith&quot;},{&quot;first_name&quot;:&quot;Sam&quot;,&quot;last_name&quot;:&quot;Chao&quot;},{&quot;first_name&quot;:&quot;Barri&quot;,&quot;last_name&quot;:&quot;Wautlet&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Mortillo&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Jeyaseelan&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Kukral&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;T. Hunt&quot;},{&quot;first_name&quot;:&quot;Amrita&quot;,&quot;last_name&quot;:&quot;Kamath&quot;},{&quot;first_name&quot;:&quot;Aberra&quot;,&quot;last_name&quot;:&quot;Fura&quot;},{&quot;first_name&quot;:&quot;Viral&quot;,&quot;last_name&quot;:&quot;Vyas&quot;},{&quot;first_name&quot;:&quot;Punit&quot;,&quot;last_name&quot;:&quot;Marathe&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;D'Arienzo&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;Derbin&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Fargnoli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2006&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;49&quot;,&quot;pages&quot;:&quot;2143-2146&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm051106d&quot;},&quot;abstract&quot;:&quot;A series of substituted 4-(4-fluoro-1H-indol-5-yloxy)pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of vascular endothelial growth factor receptor-2 kinase is reported. Structure−activity relationship studies revealed that a methyl group at the 5-position and a substituted alkoxy group at the 6-position of the pyrrolo[2,1-f][1,2,4]triazine core gave potent compounds. Biochemical potency, kinase selectivity, and pharmacokinetics of the series were optimized and in vitro safety liabilities were minimized to afford BMS-540215 (12), which demonstrated robust preclinical in vivo activity in human tumor xenograft models. The l-alanine prodrug of 12, BMS-582664 (21), is currently under evaluation in clinical trials for the treatment of solid tumors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm051106d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm051106d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm051106d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm051106d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm051106d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm051106d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm051106d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm051106d&amp;href=/doi/10.1021/jm051106d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm051106d" /></input><a href="/doi/pdf/10.1021/jm051106d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (77 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm051106d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm051106d%26sid%3Dliteratum%253Aachs%26pmid%3D16570908%26genre%3Darticle%26aulast%3DBhide%26date%3D2006%26atitle%3DDiscovery%2Band%2BPreclinical%2BStudies%2Bof%2B%2528R%2529-1-%25284-%25284-Fluoro-2-methyl-1H-indol-5-yloxy%2529-5-%2Bmethylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propan-%2B2-ol%2B%2528BMS-540215%2529%252C%2Ban%2BIn%2BVivo%2BActive%2BPotent%2BVEGFR-2%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D49%26issue%3D7%26spage%3D2143%26epage%3D2146%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/49/7" title="Go to Volume 49, Issue 7"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Volume 49, Issue 7"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106dn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106dn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm051106d&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of substituted 4-(4-fluoro-1<i>H</i>-indol-5-yloxy)pyrrolo[2,1-<i>f</i>][1,2,4]triazine-based inhibitors of vascular endothelial growth factor receptor-2 kinase is reported. Structure−activity relationship studies revealed that a methyl group at the 5-position and a substituted alkoxy group at the 6-position of the pyrrolo[2,1-<i>f</i>][1,2,4]triazine core gave potent compounds. Biochemical potency, kinase selectivity, and pharmacokinetics of the series were optimized and in vitro safety liabilities were minimized to afford BMS-540215 (<b>12</b>), which demonstrated robust preclinical in vivo activity in human tumor xenograft models. The <span class="smallcaps smallerCapital">l</span>-alanine prodrug of <b>12</b>, BMS-582664 (<b>21</b>), is currently under evaluation in clinical trials for the treatment of solid tumors. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm051106dAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom the correspondence should be addressed. Phone:  609-252-4395, Fax:  609-252-3993. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d1a3b0bbb4b4a7ffb3b9b8b5b491b3bca2ffb2bebc">[email protected]</a></p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i3" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i3"> </h2><div class="NLM_p">Inhibition of tumor angiogenesis as a means of tumor growth arrest has been an area of intense research interest over the past decade.<sup><a onclick="showRef(event, 'jm051106db00001'); return false;" href="javascript:void(0);" class="ref jm051106db00001">1</a></sup> Vascular endothelial growth factor (VEGF) isoforms and their cognate tyrosine kinase receptors (VEGFRs) have been especially attractive targets for the inhibition of angiogenesis.<sup><a onclick="showRef(event, 'jm051106db00002 jm051106db00003'); return false;" href="javascript:void(0);" class="ref jm051106db00002 jm051106db00003">2,3</a></sup> VEGFR-2 is of particular interest because it is the principal kinase involved in multiple processes of angiogenesis, including vascular permeability, endothelial cell (EC) proliferation, migration, and survival.<sup><a onclick="showRef(event, 'jm051106db00004'); return false;" href="javascript:void(0);" class="ref jm051106db00004">4</a></sup> As a result, VEGFR-2 has become a compelling target for small molecule kinase inhibitors.<sup><a onclick="showRef(event, 'jm051106db00005'); return false;" href="javascript:void(0);" class="ref jm051106db00005">5</a></sup> Recently, clinical validation of the VEGF signaling pathway has been provided by the demonstration of an overall survival benefit in colorectal cancer patients treated with bevacizumab, a monoclonal antibody to the ligand VEGF-A, in combination with standard regimens (IFL or Saltz).<sup><a onclick="showRef(event, 'jm051106db00006'); return false;" href="javascript:void(0);" class="ref jm051106db00006">6</a></sup> Many small molecule inhibitors of the VEGFR-2 kinase domain have shown promising results in preclinical studies and are currently under clinical evaluation.<sup><a onclick="showRef(event, 'jm051106db00007'); return false;" href="javascript:void(0);" class="ref jm051106db00007">7</a></sup> Herein, we describe the identification of a selective inhibitor of VEGFR-2 kinase with robust preclinical in vivo activity and a safety profile that is suitable for chronic dosing. </div><div class="NLM_p">Recently, we reported that phenol-substituted pyrrolo[2,1-<i>f</i>][1,2,4]triazines afforded potent inhibitors of VEGFR-2 kinase but lacked good oral bioavailability.<sup><a onclick="showRef(event, 'jm051106db00008'); return false;" href="javascript:void(0);" class="ref jm051106db00008">8</a></sup> Our search for compounds with better pharmacokinetic properties led to the discovery of 4-(4-fluoro-1<i>H</i>-indol-5-yloxy)pyrrolo[2,1-<i>f</i>][1,2,4]triazines shown in Table 1<a class="ref showTableEvent internalNav" data-ID="jm051106dt00001" href="#jm051106dt00001"></a>. This report describes the synthesis, structure−activity relationships, and antitumor activity of this indole-based series of compounds. Initial structure−activity relationship studies (SAR) in the series were investigated using analogues with an ester group at the 6-position. Similar to earlier observations,<sup>8</sup> incorporation of a methyl group at the 5-position (R<sup>5</sup>), as in compound <b>2</b>, gave optimal potency against the VEGFR-2 enzyme. Although the introduction of a methyl group at the <a name="jm004900702144" id="jm004900702144"></a> 2-position of the indole ring (R<sup>2‘</sup>) did not affect the potency against VEGFR-2 (<b>2</b>,<b> 5</b>), introduction of a fluorine group at the 4-position of indole ring (R<sup>4‘</sup>) gave a 4-fold increase in potency against VEGFR-2 (<b>6</b>). <div class="NLM_table-wrap" id="jm051106dt00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  SAR at the R<sup>5</sup>, R<sup>2‘</sup>, and R<sup>4‘</sup> Positions of 4-(1<i>H</i>-Indol-5-yloxy)pyrrolo[2,1-<i>f</i>][1,2,4]triazine<i><sup>a</sup></i><sup></sup><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106du00001a.gif" alt="" id="_i4" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">R<sup>1</sup></td><td class="colsep2 rowsep2">R<sup>2‘</sup></td><td class="colsep2 rowsep2">R<sup>4‘</sup></td><td class="colsep2 rowsep2">R<sup>5</sup></td><td class="colsep2 rowsep2">VEGFR-2, IC<sub>50</sub>, μM </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>1</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.21<i><sup>b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>2</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">0.087 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>3</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">0.31 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>4</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"><i>i</i>-Pr </td><td class="colsep2 rowsep2">0.47 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>5</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">0.078 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>6</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">0.017</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> IC<sub>50</sub> values are reported as the mean of at least three individual determinations. Variability around the mean value was <50%.<i><sup>b</sup></i><sup></sup> value reported from one experiment. </p></div></div></div><div class="NLM_p">On the basis of these data, we chose to continue our SAR studies using analogues with methyl groups at R<sup>5</sup> and R<sup>2‘</sup> and with fluorine at R<sup>4‘</sup>. It was observed that the compounds with a 6-hydroxy substituent showed good enzyme potency. Therefore, our subsequent SAR studies were conducted using analogues with a 6-position ether. The ester at the 6-position was converted to a hydroxyl group (<b>7</b>) via a reduction, oxidation, and Baeyer−Villiger rearrangement sequence.<sup>8</sup> Although phenol <b>7</b> was a potent kinase inhibitor, it showed poor plasma exposure upon oral administration. Therefore, the phenol was alkylated with different groups to afford the series of 6-position ethers described in Table 2<a class="ref showTableEvent internalNav" data-ID="jm051106dt00002" href="#jm051106dt00002"></a>. Molecular modeling suggested that these compounds would bind in the ATP binding site<sup><a onclick="showRef(event, 'jm051106db00009'); return false;" href="javascript:void(0);" class="ref jm051106db00009">8,9</a></sup> and that the linkers at the 6-position would be solvent exposed. Consistent with this hypothesis, substitution at R<sup>6</sup> affected kinase activity only marginally, but allowed modulation of aqueous solubility, pharmacokinetic properties, and the in vitro safety profile. Compounds containing an amine, alcohol, or ether group on the R<sup>6</sup> tether (Table 2) were potent against the VEGFR-2 enzyme, whereas analogues containing a sulfone (<b>15</b>) or a sulfonamide (<b>16</b>) exhibited moderate potency. In 4 h oral exposure studies in mice, amines generally had modest in vivo exposures (<b>8</b>−<b>11</b>), whereas compounds with an alcohol, sulfone, or sulfonamide group (<b>12</b> to <b>16</b>) showed high oral exposures. <div class="NLM_table-wrap" id="jm051106dt00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  SAR at R<sup>6</sup> Linker</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106du00002a.gif" alt="" id="_i5" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> IC<sub>50</sub> values are reported as the mean of at least three individual determinations or as individual IC<sub>50</sub> values in the case of less than three measurements. Variability around the mean value was <50%. For assay conditions see ref 9.<i><sup>b</sup></i><sup></sup> Compounds were evaluated in 4 h exposure study in mice at 50 mg/kg and formulated as solutions in 7:1:2 poly(ethylene glycol)400:ethanol:water.<i><sup>c</sup></i><sup></sup> For CYP inhibition assay details see ref 9.<i><sup>d</sup></i><sup></sup> ND, data not determined; <i><sup>e</sup></i><sup></sup> See Supporting Information.</p></div></div></div><div class="NLM_p">Compounds in Table 2 were further differentiated by their activity in hERG patch-clamp and CYP3A4 liability assays. Compounds with an amino group on the side chain (<b>8</b>, <b>10</b>) exhibited potent hERG ion channel activity and CYP3A4 inhibition, which was reduced in the 3-hydroxypyrrolidine derivative <b>11</b>. Compounds without an amino group on the side chain (<b>12</b>,<b> 14</b>, and <b>15</b>) possessed reduced potency against the hERG ion channel and a range of activity against a panel of cytochrome P450 (CYP) isozymes.<sup>11</sup> Among the compounds tested, <b>11</b>, <b>12</b>, and <b>15</b> showed reduced inhibition of CYP3A4 activity compared to compounds <b>13</b> and <b>14</b>. On the basis of its superior enzyme potency against VEGFR-2, acceptable plasma protein binding (human 98.1%), and good exposure profile in the mouse, compound <b>12</b> was chosen for additional kinase selectivity, pharmacokinetic, and in vivo efficacy studies. </div><div class="NLM_p">The reaction sequence for the preparation of <b>12</b> is detailed in Scheme 1<a data-tab="pane-pcw-Figures" href="#jm051106dh00001" id="" class=" internalNav"></a>. The 6-position phenol <b>17</b><sup>8</sup> was first protected as a benzyl ether by treatment with benzyl bromide and K<sub>2</sub>CO<sub>3</sub> in acetonitrile. The resulting intermediate was heated in aqueous HCl at 80 °C to remove the phenyl ether protecting group at the 4-position to obtain <b>18 </b>in 64% yield over two steps. The 4-oxo group of <b>18 </b>was converted to chloroimidate <b>19</b> by treatment with phosphorus oxychloride at 110 °C. Reaction of 4-fluoro-5-hydroxy-2-methylindole<sup><a onclick="showRef(event, 'jm051106db00010'); return false;" href="javascript:void(0);" class="ref jm051106db00010">10</a></sup><b>20</b> with crude <b>19</b> in DMF in the presence of NaH and hydrogenolysis of the resulting 6-benzylated intermediate with ammonium formate and 10% palladium on carbon afforded the key compound <b>7</b> in 76% overall yield. Treatment of <b>7</b> with (<i>R</i>)-(+)-propylene oxide in ethanol at 70 °C in the presence of triethylamine afforded <b>12</b> with high optical purity (99.5% ee). <div id="_i6"><figure id="jm051106dh00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106dh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106dh00001.jpeg" id="_i7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  Synthesis of <b>12</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and reaction conditions:  (a) benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, 70 °C; (b) 1 N HCl, 80 °C, 64%, two steps; (c) POCl<sub>3</sub>, 110 °C; (d) DMF, NaH, 76%, two steps; (e) 10% Pd/C, HCOONH<sub>4</sub>, DMF, 86%; (f) (<i>R</i>)-(+)-propylene oxide, Et<sub>3</sub>N, EtOH, 70 °C, 53%.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106dh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm051106d&amp;id=jm051106dh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p"><a name="jm004900702145" id="jm004900702145"></a>The enzyme kinetics and kinase selectivity profile of <b>12</b> were examined (Table 3<a class="ref showTableEvent internalNav" data-ID="jm051106dt00003" href="#jm051106dt00003"></a>). Compound <b>12</b> was found to be an ATP competitive inhibitor of human VEGFR-2, with a <i>K</i><sub>i</sub> of 26 nM. It had moderate potency against two of three other kinases implicated in angiogenesis, VEGFR-1 and FGFR-1, but it exhibited good selectivity against PDGFR-β.<sup><a onclick="showRef(event, 'jm051106db00011'); return false;" href="javascript:void(0);" class="ref jm051106db00011">11</a></sup> Since compound <b>12</b> targets the mouse endothelial cells rather than the human tumor cells in the preclinical in vivo mouse models, it was also tested and found to be good inhibitor of Flk-1, the mouse homologue of VEGFR-2. Compound <b>12</b> showed good selectivity against a variety of other receptor and nonreceptor kinases as shown in Table 3. It should be noted that AZD2171<sup>7f</sup> which also contains fluoroindole group <b>20</b> on a quinazoline nucleus, exhibits potent activity against PDGFR-β and c-Kit kinases. <div class="NLM_table-wrap" id="jm051106dt00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Kinase Selectivity Profile of <b>12</b></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">enzyme</td><td class="colsep2 rowsep2">IC<sub>50</sub> (nM)</td><td class="colsep2 rowsep2"><i>K</i><sub>i</sub> (nM) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">VEGFR-2 (human) </td><td class="colsep2 rowsep2">25 </td><td class="colsep2 rowsep2">26 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Flk-1 (mouse) </td><td class="colsep2 rowsep2">89 </td><td class="colsep2 rowsep2">28 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">VEGFR-1 </td><td class="colsep2 rowsep2">380 </td><td class="colsep2 rowsep2">60 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">FGFR-1 </td><td class="colsep2 rowsep2">148 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PDGFR-β </td><td class="colsep2 rowsep2">>6000 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">EGFR </td><td class="colsep2 rowsep2">>1900 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">LCK </td><td class="colsep2 rowsep2">>2500 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PKCα </td><td class="colsep2 rowsep2">>25000 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">JAK-3 </td><td class="colsep2 rowsep2">>50000 </td><td class="colsep2 rowsep2"> </td></tr></tbody></table></div></div></div><div class="NLM_p">Inhibition of proliferation of human umbilical vein endothelial cells (HUVEC) by <b>12</b> was investigated. Following stimulation by growth factors VEGF-A or FGF, the inhibition of proliferation of HUVEC cells was measured. A good correlation was observed between cellular potency and activity against the isolated enzymes with potency against VEGF-stimulated HUVECs (40 nM) being higher than against FGF-stimulated HUVECs (276 nM).<sup>11</sup> When tested against a panel of human tumor cell lines, <b>12</b> showed lower antiproliferative potency (IC<sub>50</sub> > 2 μM). In particular, activity was low against the cell line used in the in vivo tumor xenograft mouse efficacy model (human breast carcinoma H3396), supporting the concept that the efficacy of the compound is driven by its antiangiogenic properties. </div><div class="NLM_p">In a mouse (male Balb-c) pharmacokinetic study<sup>11</sup> (Table 4<a class="ref showTableEvent internalNav" data-ID="jm051106dt00004" href="#jm051106dt00004"></a>) <b>12</b> was administered at 60 mg/kg orally as a solution in PEG400:Tween80 (75:25) and at 10 mg/kg intravenously in PEG400:water (3:2). The compound was rapidly absorbed with <i>T</i><sub>max</sub> of 1 h, a favorable half-life (<i>t</i><sub>1/2</sub>) of 2.7 h, and mean residence time (MRT) of 3.6 h. The measured oral bioavailability (<i>F</i><sub>po</sub>) in this experiment was 88%. The steady-state volume of distribution (<i>V</i><sub>ss</sub>) was high, indicating extensive extravascular distribution, and systemic clearance (Cl) was much lower than the hepatic blood flow. <div class="NLM_table-wrap" id="jm051106dt00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  Parameters for<b>12 </b>in a 24 Hour PK Study in Mice<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">dose, mg/kg</td><td class="colsep2 rowsep2">AUC<sub>tot</sub>, μM·h</td><td class="colsep2 rowsep2"><i>t</i><sub>1/2</sub>, h</td><td class="colsep2 rowsep2">MRT, h</td><td class="colsep2 rowsep2">Cl, mL/min/kg</td><td class="colsep2 rowsep2"><i>V</i><sub>ss</sub>, L/kg</td><td class="colsep2 rowsep2"><i>F</i><sub>po</sub>, % </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">iv, 10 </td><td class="colsep2 rowsep2">49 </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">3.6 </td><td class="colsep2 rowsep2">9.3 </td><td class="colsep2 rowsep2">2.0 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">po, 60 </td><td class="colsep2 rowsep2">224 </td><td class="colsep2 rowsep2">3.6 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">88</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Data taken from an average of three animals. For assay details see ref 9.</p></div></div></div><div class="NLM_p">The in vivo efficacy of <b>12</b> was evaluated against H3396 xenografts in athymic mice (Figure 1<a data-tab="pane-pcw-Figures" href="#jm051106df00001" id="" class=" internalNav"></a>). Once daily oral administration of <b>12</b> as a solution in PEG 400:water (7:3) for 10 days (days 14 to 23 post implant) inhibited the growth of established tumors (staged to 80−120 mm<sup>3</sup> size) in a dose dependent manner. At 60 and 90 mg/kg doses, nearly complete inhibition of growth was observed throughout the dosing period, with tumor growth inhibition<sup>11</sup> of 85% and 97%, respectively. No overt toxicity as measured by weight loss and morbidity was observed in either cohort of animals, suggesting good safety. <div id="_i8"><figure id="jm051106df00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106df00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106df00001.jpeg" id="_i9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 In vivo antitumor activity of <b>12</b> versus H3396 xenografts in athymic mice with dosing once a day for 10 days from day 14 to day 23 postimplant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106df00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm051106d&amp;id=jm051106df00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Solid dosage formulations of compound <b>12</b> were assessed in the rat to support advancement of this compound as a development candidate. Rats were dosed with micronized <b>12</b> as a suspension in water to mimic the solid dosage formulation which would be used in the clinic. At 25 mg/kg, micronized suspensions afforded significantly lower systemic exposures than those obtained from solution formulations (Table 5<a class="ref showTableEvent internalNav" data-ID="jm051106dt00005" href="#jm051106dt00005"></a>). Additionally, drug exposure did not increase proportionally with dose, suggesting that nonlinear pharmacokinetics in humans could present a development issue. <div class="NLM_table-wrap" id="jm051106dt00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  Rat 24 Hour PK Study of <b>12</b><i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">solution</td><td class="colsep2 rowsep2" colspan="3">micronized suspension</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">dose (mg/kg)</td><td class="colsep2 rowsep2">25</td><td class="colsep2 rowsep2">25</td><td class="colsep2 rowsep2">100</td><td class="colsep2 rowsep2">200 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>C</i><sub>max </sub>(μM) </td><td class="colsep2 rowsep2">6.4 </td><td class="colsep2 rowsep2">0.55 </td><td class="colsep2 rowsep2">2.05 </td><td class="colsep2 rowsep2">1.71 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">AUC<sub>tot </sub>(μM·h) </td><td class="colsep2 rowsep2">13.4 </td><td class="colsep2 rowsep2">3.35 </td><td class="colsep2 rowsep2">8.43 </td><td class="colsep2 rowsep2">7.61</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Vehicle for solution study was PEG400:ethanol:water (7:1:2) and for suspension study was water with 0.1% tween 80.</p></div></div></div><div class="NLM_p">Low aqueous solubility at equilibrium (<1 μg/mL at pH 6.5) and low p<i>K</i><sub>a</sub> (2.8) were believed to be contributing to the observed poor absorption from solid dosage form. Prodrug formation was recognized as an effective means to improve the pharmaceutic and pharmacokinetic properties of this otherwise attractive development candidate. The successful outcome of this strategy will be reported on shortly in a subsequent manuscript, which will describe the prodrug <b>21</b> (Figure 2<a data-tab="pane-pcw-Figures" href="#jm051106df00002" id="" class=" internalNav"></a>) which is currently in clinical development. <div id="_i10"><figure id="jm051106df00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106df00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106df00002.jpeg" id="_i11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Structure of <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106df00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm051106d&amp;id=jm051106df00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">In summary, a novel series of 4-(4-fluoro-1<i>H</i>-indol-5-yloxy)pyrrolo[2,1-<i>f</i>][1,2,4]triazines with potent VEGFR-2 activity was identified. Structure−activity relationship studies led to the discovery of (<i>R</i>)-1-(4-(4-fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan-2-ol (<b>12</b>) as <a name="jm004900702146" id="jm004900702146"></a> an orally active compound in the H3396 xenograft model of human breast carcinoma, demonstrating almost complete tumor growth stasis during the dosing period. On the basis of its excellent enzymatic potency against VEGFR-2, good kinase selectivity profile, and acceptable safety profile, compound <b>12</b> was considered as a candidate for further development and its prodrug formation was considered to improve pharmaceutics properties. </div></div><div class="NLM_back"><div class="NLM_notes" id=""><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13"><a href="/doi/suppl/10.1021%2Fjm051106d">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Characterization data for compounds <b>1</b>−<b>16</b>. Full experimental details and the characterization data for compound <b>12</b>. This material is available free of charge on the web at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm051106d/suppl_file/jm051106dsi20060213_033827.pdf">jm051106dsi20060213_033827.pdf (78.4 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm051106d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajeev S. Bhide</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhen-Wei Cai</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong-Zheng Zhang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ligang Qian</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donna Wei</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie Barbosa</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis J. Lombardo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert M. Borzilleri</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoping Zheng</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurence I. Wu</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel C. Barrish</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Soong-Hoon Kim</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth Leavitt</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arvind Mathur</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leslie Leith</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sam Chao</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barri Wautlet</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Mortillo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Jeyaseelan</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Kukral</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John T. Hunt</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amrita Kamath</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aberra Fura</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Viral Vyas</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Punit Marathe</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia D'Arienzo</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George Derbin</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Fargnoli</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank George Trainor and Robert Kramer for scientific advice, and the Discovery analytical sciences for compound characterization. </p></div><div class="refs-header-label"></div><p class="references-count">
            This article references 11 other publications.
        </p><ol id="references" class="useLabel"><li id="jm051106db00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm051106db00001_1"><span><span class="NLM_string-ref">(a) Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. <i>  Nat. Med</i>. <b>1995</b>, <i>1</i>, 27−31.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=31&author=J+Folkman&title=Angiogenesis+in+cancer%2C+vascular%2C+rheumatoid+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DAngiogenesis%2520in%2520cancer%252C%2520vascular%252C%2520rheumatoid%2520and%2520other%2520diseases%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm051106db00001_2"><span><span class="NLM_string-ref">(b) Carmeliet, P.; Jain, R. K. Angiogenesis in cancer and other diseases. <i>  Nature</i><b>2000</b>, <i>407</i>, 249−257.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=257&author=P.+Carmeliet&author=R.+K+Jain&title=Angiogenesis+in+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00001_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm051106db00002_1"><span><span class="NLM_string-ref">Traxler, P. Tyrosine kinases as targets in cancer therapy − successes and failures. <i>  Exp. Opin. Ther. Targets</i><b>2003</b>, <i>7</i>, 215.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=215&author=P+Traxler&title=Tyrosine+kinases+as+targets+in+cancer+therapy+%E2%88%92+successes+and+failures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520in%2520cancer%2520therapy%2520%25E2%2588%2592%2520successes%2520and%2520failures%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Targets%26date%3D2003%26volume%3D7%26spage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm051106db00003_1"><span><span class="NLM_string-ref">Shawver, L. K.; Lipson, K. E.; Fong, T. A. T.; McMahon, G.; Plowman, G. D.; Strawn, L. M. Receptor tyrosine kinases as targets for inhibition of angiogenesis. <i>  Drug Discovery Today</i><b>1997</b>, <i>2</i>, 50−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=63&author=L.+K.+Shawver&author=K.+E.+Lipson&author=T.+A.+T.+Fong&author=G.+McMahon&author=G.+D.+Plowman&author=L.+M+Strawn&title=Receptor+tyrosine+kinases+as+targets+for+inhibition+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShawver%26aufirst%3DL.%2BK.%26atitle%3DReceptor%2520tyrosine%2520kinases%2520as%2520targets%2520for%2520inhibition%2520of%2520angiogenesis%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1997%26volume%3D2%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm051106db00004_1"><span><span class="NLM_string-ref">Ferrara, N.; Gerber, H. P.; Lecouter, J. <i>  Nat. Med</i>. <b>2003</b>, <i>9</i>, 669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=jm051106db00004/jm051106db00004_1&amp;dbid=16&amp;doi=10.1021%2Fjm051106d&amp;key=10.1038%2Fnm0603-669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=jm051106db00004/jm051106db00004_1&amp;dbid=8&amp;doi=10.1021%2Fjm051106d&amp;key=12778165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=jm051106db00004/jm051106db00004_1&amp;dbid=32&amp;doi=10.1021%2Fjm051106d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Ferrara%2C+N.%3B+Gerber%2C+H.+P.%3B+Lecouter%2C+J.+Nat.+Med.+2003%2C+9%2C+669+Ferrara%2C+N.%3B+Gerber%2C+H.+P.%3B+Lecouter%2C+J.+Nat.+Med.+2003%2C+9%2C+669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_jm051106db00004_1R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of VEGF and its receptors</span></div><div class="casAuthors">Ferrara, Napoleone; Gerber, Hans-Peter; LeCouter, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">669-676</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Vascular endothelial growth factor (VEGF) is a key regulator of physiol. angiogenesis during embryogenesis, skeletal growth and reproductive functions.  VEGF has also been implicated in pathol. angiogenesis assocd. with tumors, intraocular neovascular disorders and other conditions.  The biol. effects of VEGF are mediated by two receptor tyrosine kinases (RTKs), VEGFR-1 and VEGFR-2, which differ considerably in signaling properties.  Non-signaling co-receptors also modulate VEGF RTK signaling.  Currently, several VEGF inhibitors are undergoing clin. testing in several malignancies.  VEGF inhibition is also being tested as a strategy for the prevention of angiogenesis, vascular leakage and visual loss in age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp73RlVV-BkrVg90H21EOLACvtfcHk0lggH_nknEihnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOnur4%253D&md5=7b3bc5510c26c80d75679920fbcb378e</span></div><a href="/servlet/linkout?suffix=jm051106db00004_1&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-669%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm051106db00005_1"><span><span class="NLM_string-ref">(a) Sepp-Lorenzino, L.; Thomas, K. A. Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development. <i>  Exp. Opin. Investig. Drugs</i><b>2002</b>, <i>11</i>, 1447−1465.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1465&author=L.+Sepp-Lorenzino&author=K.+A+Thomas&title=Antiangiogenic+agents+targeting+vascular+endothelial+growth+factor+and+its+receptors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26atitle%3DAntiangiogenic%2520agents%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520its%2520receptors%2520in%2520clinical%2520development%26jtitle%3DExp.%2520Opin.%2520Investig.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm051106db00005_2"><span><span class="NLM_string-ref">(b) Bilodeau, M. T.; Fraley, M. E.; Hartman, G. D. Kinase insert domain-containing receptor kinase inhibitors as anti-angiogenic agents. <i>  Exp. Opin. Invest. Drugs</i><b>2002</b>, <i>11</i>, 737−745.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=745&author=M.+T.+Bilodeau&author=M.+E.+Fraley&author=G.+D+Hartman&title=Kinase+insert+domain-containing+receptor+kinase+inhibitors+as+anti-angiogenic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00005_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DKinase%2520insert%2520domain-containing%2520receptor%2520kinase%2520inhibitors%2520as%2520anti-angiogenic%2520agents%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm051106db00005_3"><span><span class="NLM_string-ref">(c) Underiner, T. L.; Ruggeri, B.; Gingrich, D. E. Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. <i>  Curr. Med. Chem.</i><b>2004</b>, <i>11</i>, 731−745.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=745&author=T.+L.+Underiner&author=B.+Ruggeri&author=D.+E+Gingrich&title=Development+of+vascular+endothelial+growth+factor+receptor+%28VEGFR%29+kinase+inhibitors+as+anti-angiogenic+agents+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00005_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26atitle%3DDevelopment%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528VEGFR%2529%2520kinase%2520inhibitors%2520as%2520anti-angiogenic%2520agents%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm051106db00006_1"><span><span class="NLM_string-ref">Hurwitz, H.; Fehrenbacher, L.; Novotny, W.; Cartwright, T.; Hainsworth, J.; Heim, W.; Berlin, J.; Baron, A.; Griffing, S.; Holmgren, E.; Ferrara, N.; Fyfe, G.; Rogers, B.; Ross, R.; Kabbinavar, F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. <i>  New Engl. J. Med.</i><b>2004</b>, <i>350</i>, 2335−2342.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2342&author=H.+Hurwitz&author=L.+Fehrenbacher&author=W.+Novotny&author=T.+Cartwright&author=J.+Hainsworth&author=W.+Heim&author=J.+Berlin&author=A.+Baron&author=S.+Griffing&author=E.+Holmgren&author=N.+Ferrara&author=G.+Fyfe&author=B.+Rogers&author=R.+Ross&author=F+Kabbinavar&title=Bevacizumab+plus+irinotecan%2C+fluorouracil%2C+and+leucovorin+for+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DH.%26atitle%3DBevacizumab%2520plus%2520irinotecan%252C%2520fluorouracil%252C%2520and%2520leucovorin%2520for%2520metastatic%2520colorectal%2520cancer%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm051106db00007_1"><span><span class="NLM_string-ref">(a) Wood, J. M.; Bold, G.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Frei, J.; Hofmann, F.; Mestan, J.; Mett, H.; O'Reilly, T.; Persohn, E.; Rösel, J.; Schnell, C.; Stover, D.; Theuer, A.; Towbin, H.; Wenger, F.; Woods-Cook, K.; Menrad, A.; Siemeister, G.; Schirner, M.; Thierauch, K.-H.; Schneider, M. R.; Drevs, J.; Martiny-Baron, G.; Totzke, F.; Marmé, D. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. <i>  Cancer Res. </i><b>2000</b>, <i>60</i>, 2178−2189.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=2189&author=J.+M.+Wood&author=G.+Bold&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=J.+Frei&author=F.+Hofmann&author=J.+Mestan&author=H.+Mett&author=T.+O%27Reilly&author=E.+Persohn&author=J.+R%C3%B6sel&author=C.+Schnell&author=D.+Stover&author=A.+Theuer&author=H.+Towbin&author=F.+Wenger&author=K.+Woods-Cook&author=A.+Menrad&author=G.+Siemeister&author=M.+Schirner&author=K.-H.+Thierauch&author=M.+R.+Schneider&author=J.+Drevs&author=G.+Martiny-Baron&author=F.+Totzke&author=D.+Marm%C3%A9&title=a+novel+and+potent+inhibitor+of+vascular+endothelial+growth+factor+receptor+tyrosine+kinases%2C+impairs+vascular+endothelial+growth+factor-induced+responses+and+tumor+growth+after+oral+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3Da%2520novel%2520and%2520potent%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinases%252C%2520impairs%2520vascular%2520endothelial%2520growth%2520factor-induced%2520responses%2520and%2520tumor%2520growth%2520after%2520oral%2520administration%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm051106db00007_2"><span><span class="NLM_string-ref">(b) Abrams, T. J.; Murray, L. J.; Pesenti, E.; Walker Holway, V.; Colombo, T.; Lee, L. B.; Cherrington, J. M.; Pryer, N. K. Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer. <i>  Mol. Cancer Ther.</i><b>2003</b>, <i>2</i>, 1011−1021.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1021&author=T.+J.+Abrams&author=L.+J.+Murray&author=E.+Pesenti&author=V.+Walker+Holway&author=T.+Colombo&author=L.+B.+Lee&author=J.+M.+Cherrington&author=N.+K.+Pryer&author=+Preclinical&title=%E2%80%9Cstandard+of+care%E2%80%9D+therapeutic+agents+for+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbrams%26aufirst%3DT.%2BJ.%26atitle%3D%25E2%2580%259Cstandard%2520of%2520care%25E2%2580%259D%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm051106db00007_3"><span><span class="NLM_string-ref">(c) Hennequin, L. F.; Stokes, E. S. E.; Thomas, A. P.; Johnstone, C.; Plé, P. A.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Kendrew, J.; Curwen, J. O. Novel 4-anilinoquinazolines with C-7 basic side chains:  design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. <i>  J. Med. Chem.</i><b>2002</b>, <i>45</i>, 1300−1312.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1312&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=A.+P.+Thomas&author=C.+Johnstone&author=P.+A.+Pl%C3%A9&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+Kendrew&author=J.+O.+Curwen&author=+Novel&title=basic+side+chains%3A%E2%80%89+design+and+structure+activity+relationship+of+a+series+of+potent%2C+orally+active%2C+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3Dbasic%2520side%2520chains%253A%25E2%2580%2589%2520design%2520and%2520structure%2520activity%2520relationship%2520of%2520a%2520series%2520of%2520potent%252C%2520orally%2520active%252C%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm051106db00007_4"><span><span class="NLM_string-ref">(d) Beebe, J. S.; Jani, J. P.; Knauth, E.; Goodwin, P.; Higdon, C.; Rossi, A. M.; Emerson, E.; Finkelstein, M.; Floyd, E.; Harriman, S.; Atherton, J.; Hillerman, S.; Soderstrom, C.; Kou, K.; Gant, T.; Noe, M. C.; Foster, B.; Rastinejad, F.; Marx, M. A.; Schaeffer, T.; Whalen, P. M.; Roberts, W. G. Pharmacological characterizat ion of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 7301−7309.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7309&author=J.+S.+Beebe&author=J.+P.+Jani&author=E.+Knauth&author=P.+Goodwin&author=C.+Higdon&author=A.+M.+Rossi&author=E.+Emerson&author=M.+Finkelstein&author=E.+Floyd&author=S.+Harriman&author=J.+Atherton&author=S.+Hillerman&author=C.+Soderstrom&author=K.+Kou&author=T.+Gant&author=M.+C.+Noe&author=B.+Foster&author=F.+Rastinejad&author=M.+A.+Marx&author=T.+Schaeffer&author=P.+M.+Whalen&author=W.+G+Roberts&title=Pharmacological+characterizat+ion+of+CP-547%2C632%2C+a+novel+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitor+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DJ.%2BS.%26atitle%3DPharmacological%2520characterizat%2520ion%2520of%2520CP-547%252C632%252C%2520a%2520novel%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitor%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm051106db00007_5"><span><span class="NLM_string-ref">(e) Gingrich, D. E.; Reddy, D. R.; Iqbal, M. A.; Singh, J.; Aimone, L. D.; Angeles, T. S.; Albom, M.; Yang, S.; Ator, M. A.; Meyer, S. L.; Robinson, C.; Ruggeri, B. A.; Dionne, C. A.; Vaught, J. L.; Mallamo, J. P.; Hudkins, R. L. A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors:  structure−activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 5375−5388.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5388&author=D.+E.+Gingrich&author=D.+R.+Reddy&author=M.+A.+Iqbal&author=J.+Singh&author=L.+D.+Aimone&author=T.+S.+Angeles&author=M.+Albom&author=S.+Yang&author=M.+A.+Ator&author=S.+L.+Meyer&author=C.+Robinson&author=B.+A.+Ruggeri&author=C.+A.+Dionne&author=J.+L.+Vaught&author=J.+P.+Mallamo&author=R.+L+Hudkins&title=A+new+class+of+potent+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors%3A%E2%80%89+structure%E2%88%92activity+relationships+for+a+series+of+9-alkoxymethyl-12-%283-hydroxypropyl%29indeno%5B2%2C1-a%5Dpyrrolo%5B3%2C4-c%5Dcarbazole-5-ones+and+the+identification+of+CEP-5214+and+its+dimethylglycine+ester+prodrug+clinical+candidate+CEP-7055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520structure%25E2%2588%2592activity%2520relationships%2520for%2520a%2520series%2520of%25209-alkoxymethyl-12-%25283-hydroxypropyl%2529indeno%255B2%252C1-a%255Dpyrrolo%255B3%252C4-c%255Dcarbazole-5-ones%2520and%2520the%2520identification%2520of%2520CEP-5214%2520and%2520its%2520dimethylglycine%2520ester%2520prodrug%2520clinical%2520candidate%2520CEP-7055%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm051106db00007_6"><span><span class="NLM_string-ref">(f) Wedge, S. R.; Kendrew, J.; Hennequin, L. F.; Valentine, P. J.; Barry, S. T.; Brave, S. R.; Smith, N. R.; James, N. H.; Dukes, M.; Curwen, J. O.; Chester, R.; Jackson, J. A.; Boffey, S. J.; Kilburn, L. L.; Barnett, S.; Richmond, G. H. P.; Wadsworth, P. F.; Walker, M.; Bigley, A. L.; Taylor, S. T.; Cooper, L.; Beck, S.; Jurgensmeier, J. M.; Ogilvie, D. J. AZD2171:  A highly potent, orally bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the treatment of Cancer. <i>  Cancer </i><i>Res</i>. <b>2005</b>, <i>65</i>, 4389−4400.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4400&author=S.+R.+Wedge&author=J.+Kendrew&author=L.+F.+Hennequin&author=P.+J.+Valentine&author=S.+T.+Barry&author=S.+R.+Brave&author=N.+R.+Smith&author=N.+H.+James&author=M.+Dukes&author=J.+O.+Curwen&author=R.+Chester&author=J.+A.+Jackson&author=S.+J.+Boffey&author=L.+L.+Kilburn&author=S.+Barnett&author=G.+H.+P.+Richmond&author=P.+F.+Wadsworth&author=M.+Walker&author=A.+L.+Bigley&author=S.+T.+Taylor&author=L.+Cooper&author=S.+Beck&author=J.+M.+Jurgensmeier&author=D.+J.+Ogilvie&author=+Vascular+Endothelial+Growth+Factor&title=Inhibitor+for+the+treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26atitle%3DInhibitor%2520for%2520the%2520treatment%2520of%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm051106db00008_1"><span><span class="NLM_string-ref">Borzilleri, R. M.; Fargnoli, J.; Fura, A.; Gerhardt, T.; Hunt, J. T.; Mortillo, S.; Qian, L.; Tokarski, J.; Vyas, V.; Wautlet, B.; Zheng, X.; Bhide, R. S. Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazine based VEGFR-2 kinase inhibitors. <i>  Bioorg. Med. Chem. Lett.</i><b>2005</b>, <i>15</i>, 1429.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1429&author=R.+M.+Borzilleri&author=J.+Fargnoli&author=A.+Fura&author=T.+Gerhardt&author=J.+T.+Hunt&author=S.+Mortillo&author=L.+Qian&author=J.+Tokarski&author=V.+Vyas&author=B.+Wautlet&author=X.+Zheng&author=R.+S+Bhide&title=Synthesis+and+SAR+of+4-%283-hydroxyphenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+based+VEGFR-2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25283-hydroxyphenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520based%2520VEGFR-2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm051106db00009_1"><span><span class="NLM_string-ref">Borzilleri, R. M.; Zheng, X.; Qian, L.; Ellis, C.; Cai, Z.-W.; Wautlet, B.; Mortillo, S.; Jeyaseelan, R.; Kukral, D. W.; Fura, A.; Kamath, A.; Vyas, V.; Tokarski, J. S.; Barrish, J. C.; Hunt, J. T.; Lombardo, L. J.; Fargnoli, J.; Bhide, R. S. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 3991−4008.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Borzilleri%2C+R.+M.%3B+Zheng%2C+X.%3B+Qian%2C+L.%3B+Ellis%2C+C.%3B+Cai%2C+Z.-W.%3B+Wautlet%2C+B.%3B+Mortillo%2C+S.%3B+Jeyaseelan%2C+R.%3B+Kukral%2C+D.+W.%3B+Fura%2C+A.%3B+Kamath%2C+A.%3B+Vyas%2C+V.%3B+Tokarski%2C+J.+S.%3B+Barrish%2C+J.+C.%3B+Hunt%2C+J.+T.%3B+Lombardo%2C+L.+J.%3B+Fargnoli%2C+J.%3B+Bhide%2C+R.+S.+J.+Med.+Chem.+2005%2C+48%2C+3991%E2%88%924008.+Borzilleri%2C+R.+M.%3B+Zheng%2C+X.%3B+Qian%2C+L.%3B+Ellis%2C+C.%3B+Cai%2C+Z.-W.%3B+Wautlet%2C+B.%3B+Mortillo%2C+S.%3B+Jeyaseelan%2C+R.%3B+Kukral%2C+D.+W.%3B+Fura%2C+A.%3B+Kamath%2C+A.%3B+Vyas%2C+V.%3B+Tokarski%2C+J.+S.%3B+Barrish%2C+J.+C.%3B+Hunt%2C+J.+T.%3B+Lombardo%2C+L.+J.%3B+Fargnoli%2C+J.%3B+Bhide%2C+R.+S.+J.+Med.+Chem.2005%2C+48%2C+3991%E2%88%924008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00010"><div class="reference"><div class="NLM_citation" id="jm051106db00010_1"><span><span class="NLM_string-ref">(a) Bhide, R. S.; Fan, J.; Parlanti, L.; Barbosa, S.; Qian, L.; Cai, Z.-W.; Gibson, F. S. Process for preparing certain pyrrolotriazine compounds. PCT Int. Appl. WO 2004009542.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=009542&author=R.+S.+Bhide&author=J.+Fan&author=L.+Parlanti&author=S.+Barbosa&author=L.+Qian&author=Z.-W.+Cai&author=F.+S+Gibson&title=Process+for+preparing+certain+pyrrolotriazine+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DProcess%2520for%2520preparing%2520certain%2520pyrrolotriazine%2520compounds%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2004%26spage%3D009542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm051106db00010_2"><span><span class="NLM_string-ref">(b) Hennequin, L.; Stokes, E.; McKerrecher, D. Quinazoline derivatives as angiogenesis inhibitors. PCT Int. Appl. WO 200047212.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=47212&author=L.+Hennequin&author=E.+Stokes&author=D+McKerrecher&title=Quinazoline+derivatives+as+angiogenesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%26atitle%3DQuinazoline%2520derivatives%2520as%2520angiogenesis%2520inhibitors%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2000%26spage%3D47212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm051106db00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm051106db00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm051106db00011_1"><span><span class="NLM_string-ref">For the assay conditions of in vitro kinase, cellular proliferation, metabolic stability, cytochrome P450, and pharmacokinetic parameters, see ref 9.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+For+the+assay+conditions+of+in+vitro+kinase%2C+cellular+proliferation%2C+metabolic+stability%2C+cytochrome+P450%2C+and+pharmacokinetic+parameters%2C+see+ref+9.+For+the+assay+conditions+of+in+vitro+kinase%2C+cellular+proliferation%2C+metabolic+stability%2C+cytochrome+P450%2C+and+pharmacokinetic+parameters%2C+see+ref+9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm051106db00001':['jm051106db00001_1','jm051106db00001_2'],'jm051106db00002':['jm051106db00002_1'],'jm051106db00003':['jm051106db00003_1'],'jm051106db00004':['jm051106db00004_1'],'jm051106db00005':['jm051106db00005_1','jm051106db00005_2','jm051106db00005_3'],'jm051106db00006':['jm051106db00006_1'],'jm051106db00007':['jm051106db00007_1','jm051106db00007_2','jm051106db00007_3','jm051106db00007_4','jm051106db00007_5','jm051106db00007_6'],'jm051106db00008':['jm051106db00008_1'],'jm051106db00009':['jm051106db00009_1'],'jm051106db00010':['jm051106db00010_1','jm051106db00010_2'],'jm051106db00011':['jm051106db00011_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 96 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Yulan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Xianjie  Chen</span>, <span class="hlFld-ContribAuthor ">Yinglei  Gao</span>, <span class="hlFld-ContribAuthor ">Chunpu  Li</span>, <span class="hlFld-ContribAuthor ">Yulong  He</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6018-6035. <a href="https://doi.org/10.1021/acs.jmedchem.7b00076" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00076%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BEvaluation%252Bof%252BNovel%252BMultisubstituted%252BPyridin-3-amine%252BDerivatives%252Bas%252BMultitargeted%252BProtein%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DZhu%26aufirst%3DWei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23012017%26date%3D17072017%26date%3D27072017%26date%3D22062017%26volume%3D60%26issue%3D14%26spage%3D6018%26epage%3D6035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel H.  Myers</span>, <span class="hlFld-ContribAuthor ">Valerie G.  Brunton</span>, and <span class="hlFld-ContribAuthor ">Asier  Unciti-Broceta</span>  . </span><span class="cited-content_cbyCitation_article-title">AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3593-3608. <a href="https://doi.org/10.1021/acs.jmedchem.5b01273" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01273%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAXL%252BInhibitors%252Bin%252BCancer%25253A%252BA%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DMyers%26aufirst%3DSamuel%2BH.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D14082015%26date%3D20112015%26date%3D28042016%26date%3D10112015%26volume%3D59%26issue%3D8%26spage%3D3593%26epage%3D3608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanni  Gu</span>, <span class="hlFld-ContribAuthor ">Shuni  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (2)
                                     , 422-518. <a href="https://doi.org/10.1021/acs.chemrev.5b00392" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DNext%252BGeneration%252Bof%252BFluorine-Containing%252BPharmaceuticals%25252C%252BCompounds%252BCurrently%252Bin%252BPhase%252BII%2525E2%252580%252593III%252BClinical%252BTrials%252Bof%252BMajor%252BPharmaceutical%252BCompanies%25253A%252BNew%252BStructural%252BTrends%252Band%252BTherapeutic%252BAreas%26aulast%3DZhou%26aufirst%3DYu%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06072015%26date%3D12012016%26date%3D27012016%26volume%3D116%26issue%3D2%26spage%3D422%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul C.  Lobben</span>, <span class="hlFld-ContribAuthor ">Evan  Barlow</span>, <span class="hlFld-ContribAuthor ">James S.  Bergum</span>, <span class="hlFld-ContribAuthor ">Alan  Braem</span>, <span class="hlFld-ContribAuthor ">Shih-Ying  Chang</span>, <span class="hlFld-ContribAuthor ">Frank  Gibson</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Kopp</span>, <span class="hlFld-ContribAuthor ">Chiajen  Lai</span>, <span class="hlFld-ContribAuthor ">Thomas L.  LaPorte</span>, <span class="hlFld-ContribAuthor ">David K.  Leahy</span>, <span class="hlFld-ContribAuthor ">Jale  Müslehiddinoğlu</span>, <span class="hlFld-ContribAuthor ">Fernando  Quiroz</span>, <span class="hlFld-ContribAuthor ">Dimitri  Skliar</span>, <span class="hlFld-ContribAuthor ">Lori  Spangler</span>, <span class="hlFld-ContribAuthor ">Sushil  Srivastava</span>, <span class="hlFld-ContribAuthor ">Daniel  Wasser</span>, <span class="hlFld-ContribAuthor ">John  Wasylyk</span>, <span class="hlFld-ContribAuthor ">Robert  Wethman</span>, and <span class="hlFld-ContribAuthor ">Zhongmin  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Control Strategy for the Manufacture of Brivanib Alaninate, a Novel Pyrrolotriazine VEGFR/FGFR Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (8)
                                     , 900-907. <a href="https://doi.org/10.1021/op500126u" title="DOI URL">https://doi.org/10.1021/op500126u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op500126u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop500126u%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DControl%252BStrategy%252Bfor%252Bthe%252BManufacture%252Bof%252BBrivanib%252BAlaninate%25252C%252Ba%252BNovel%252BPyrrolotriazine%252BVEGFR%25252FFGFR%252BInhibitor%26aulast%3DLobben%26aufirst%3DPaul%2BC.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D15042014%26date%3D29052014%26date%3D21082015%26date%3D15052014%26volume%3D19%26issue%3D8%26spage%3D900%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaan A.  Pesti</span>, <span class="hlFld-ContribAuthor ">Thomas  LaPorte</span>, <span class="hlFld-ContribAuthor ">John E.  Thornton</span>, <span class="hlFld-ContribAuthor ">Lori  Spangler</span>, <span class="hlFld-ContribAuthor ">Frederic  Buono</span>, <span class="hlFld-ContribAuthor ">Gerard  Crispino</span>, <span class="hlFld-ContribAuthor ">Frank  Gibson</span>, <span class="hlFld-ContribAuthor ">Paul  Lobben</span>, and <span class="hlFld-ContribAuthor ">Christos G.  Papaioannou</span>  . </span><span class="cited-content_cbyCitation_article-title">Commercial Synthesis of a Pyrrolotriazine–Fluoroindole Intermediate to Brivanib Alaninate: Process Development Directed toward Impurity Control. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2014,</strong> <em>18 </em>
                                    (1)
                                     , 89-102. <a href="https://doi.org/10.1021/op400242j" title="DOI URL">https://doi.org/10.1021/op400242j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op400242j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop400242j%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DCommercial%252BSynthesis%252Bof%252Ba%252BPyrrolotriazine%2525E2%252580%252593Fluoroindole%252BIntermediate%252Bto%252BBrivanib%252BAlaninate%25253A%252BProcess%252BDevelopment%252BDirected%252Btoward%252BImpurity%252BControl%26aulast%3DPesti%26aufirst%3DJaan%2BA.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D01092013%26date%3D10122013%26date%3D17012014%26date%3D02122013%26volume%3D18%26issue%3D1%26spage%3D89%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, and <span class="hlFld-ContribAuthor ">Silvia  Schenone</span>  . </span><span class="cited-content_cbyCitation_article-title">Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (24)
                                     , 10797-10822. <a href="https://doi.org/10.1021/jm301085w" title="DOI URL">https://doi.org/10.1021/jm301085w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301085w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301085w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVascular%252BEndothelial%252BGrowth%252BFactor%252B%252528VEGF%252529%252BReceptors%25253A%252BDrugs%252Band%252BNew%252BInhibitors%26aulast%3DMusumeci%26aufirst%3DFrancesca%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25072012%26date%3D06112012%26date%3D27122012%26date%3D25102012%26volume%3D55%26issue%3D24%26spage%3D10797%26epage%3D10822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vito  Guagnano</span>, <span class="hlFld-ContribAuthor ">Pascal  Furet</span>, <span class="hlFld-ContribAuthor ">Carsten  Spanka</span>, <span class="hlFld-ContribAuthor ">Vincent  Bordas</span>, <span class="hlFld-ContribAuthor ">Mickaël  Le Douget</span>, <span class="hlFld-ContribAuthor ">Christelle  Stamm</span>, <span class="hlFld-ContribAuthor ">Josef  Brueggen</span>, <span class="hlFld-ContribAuthor ">Michael R.  Jensen</span>, <span class="hlFld-ContribAuthor ">Christian  Schnell</span>, <span class="hlFld-ContribAuthor ">Herbert  Schmid</span>, <span class="hlFld-ContribAuthor ">Markus  Wartmann</span>, <span class="hlFld-ContribAuthor ">Joerg  Berghausen</span>, <span class="hlFld-ContribAuthor ">Peter  Drueckes</span>, <span class="hlFld-ContribAuthor ">Alfred  Zimmerlin</span>, <span class="hlFld-ContribAuthor ">Dirksen  Bussiere</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, and <span class="hlFld-ContribAuthor ">Diana  Graus Porta</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (20)
                                     , 7066-7083. <a href="https://doi.org/10.1021/jm2006222" title="DOI URL">https://doi.org/10.1021/jm2006222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2006222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2006222%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-%2525282%25252C6-Dichloro-3%25252C5-dimethoxy-phenyl%252529-1-%25257B6-%25255B4-%2525284-ethyl-piperazin-1-yl%252529-phenylamino%25255D-pyrimidin-4-yl%25257D-1-methyl-urea%252B%252528NVP-BGJ398%252529%25252C%252BA%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252Bthe%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BFamily%252Bof%252BReceptor%252BTyrosine%252BKinase%26aulast%3DGuagnano%26aufirst%3DVito%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D17052011%26date%3D21092011%26date%3D27102011%26volume%3D54%26issue%3D20%26spage%3D7066%26epage%3D7083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory R.  Ott</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Wells</span>, <span class="hlFld-ContribAuthor ">Tho V.  Thieu</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Quail</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Lisko</span>, <span class="hlFld-ContribAuthor ">Eugen F.  Mesaros</span>, <span class="hlFld-ContribAuthor ">Diane E.  Gingrich</span>, <span class="hlFld-ContribAuthor ">Arup K.  Ghose</span>, <span class="hlFld-ContribAuthor ">Weihua  Wan</span>, <span class="hlFld-ContribAuthor ">Lihui  Lu</span>, <span class="hlFld-ContribAuthor ">Mangeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Mark S.  Albom</span>, <span class="hlFld-ContribAuthor ">Thelma S.  Angeles</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Mark A.  Ator</span>, <span class="hlFld-ContribAuthor ">Bruce A.  Ruggeri</span>, and <span class="hlFld-ContribAuthor ">Bruce D.  Dorsey</span>  . </span><span class="cited-content_cbyCitation_article-title">2,7-Disubstituted-pyrrolo[2,1-f][1,2,4]triazines: New Variant of an Old Template and Application to the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (18)
                                     , 6328-6341. <a href="https://doi.org/10.1021/jm200758k" title="DOI URL">https://doi.org/10.1021/jm200758k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200758k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200758k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2%25252C7-Disubstituted-pyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazines%25253A%252BNew%252BVariant%252Bof%252Ban%252BOld%252BTemplate%252Band%252BApplication%252Bto%252Bthe%252BDiscovery%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252BInhibitors%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DOtt%26aufirst%3DGregory%2BR.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D13062011%26date%3D22082011%26date%3D22092011%26volume%3D54%26issue%3D18%26spage%3D6328%26epage%3D6341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-wei  Cai</span>, <span class="hlFld-ContribAuthor ">Yongzheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Ligang  Qian</span>, <span class="hlFld-ContribAuthor ">Stephanie  Barbosa</span>, <span class="hlFld-ContribAuthor ">Donna  Wei</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zheng</span>, <span class="hlFld-ContribAuthor ">Lawrence  Wu</span>, <span class="hlFld-ContribAuthor ">Junying  Fan</span>, <span class="hlFld-ContribAuthor ">Zhongping  Shi</span>, <span class="hlFld-ContribAuthor ">Barri S.  Wautlet</span>, <span class="hlFld-ContribAuthor ">Steve  Mortillo</span>, <span class="hlFld-ContribAuthor ">Robert  Jeyaseelan, Sr.</span>, <span class="hlFld-ContribAuthor ">Daniel W.  Kukral</span>, <span class="hlFld-ContribAuthor ">Amrita  Kamath</span>, <span class="hlFld-ContribAuthor ">Punit  Marathe</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">George  Derbin</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span> and <span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Brivanib Alaninate ((S)-((R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (6)
                                     , 1976-1980. <a href="https://doi.org/10.1021/jm7013309" title="DOI URL">https://doi.org/10.1021/jm7013309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm7013309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm7013309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBrivanib%252BAlaninate%252B%252528%252528S%252529-%252528%252528R%252529-1-%2525284-%2525284-Fluoro-2-methyl-1H-indol-5-yloxy%252529-5-methylpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-6-yloxy%252529propan-2-yl%2525292-aminopropanoate%252529%25252C%252BA%252BNovel%252BProdrug%252Bof%252BDual%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor-2%252Band%252BFibroblast%252BGrowth%252BFactor%252BReceptor-1%252BKinase%252BInhibitor%252B%252528BMS-540215%252529%26aulast%3DCai%26aufirst%3DZhen-wei%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D27%252003%25202008%26date%3D21%252002%25202008%26date%3D23%252010%25202007%26volume%3D51%26issue%3D6%26spage%3D1976%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yihong  Wan</span>, <span class="hlFld-ContribAuthor ">Wenyu  Wu</span>, <span class="hlFld-ContribAuthor ">Yuanda  Wan</span>, <span class="hlFld-ContribAuthor ">Liren  Li</span>, <span class="hlFld-ContribAuthor ">Jiawen  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Shuwen  Liu</span>, <span class="hlFld-ContribAuthor ">Xingang  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib alaninate inhibited dengue virus proliferation through VEGFR2/AMPK pathway. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>170 </em>, 105721. <a href="https://doi.org/10.1016/j.phrs.2021.105721" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105721%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DBrivanib%252Balaninate%252Binhibited%252Bdengue%252Bvirus%252Bproliferation%252Bthrough%252BVEGFR2%25252FAMPK%252Bpathway%26aulast%3DWan%26aufirst%3DYihong%26date%3D2021%26volume%3D170%26spage%3D105721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Liang</span>, <span class="hlFld-ContribAuthor ">Juelan  Wang</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Jun  Hou</span>, <span class="hlFld-ContribAuthor ">Yonghe  Hu</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of dual FGFR inhibitors as a novel therapy for cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113205. <a href="https://doi.org/10.1016/j.ejmech.2021.113205" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113205%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bof%252Bdual%252BFGFR%252Binhibitors%252Bas%252Ba%252Bnovel%252Btherapy%252Bfor%252Bcancer%26aulast%3DLiang%26aufirst%3DQi%26date%3D2021%26volume%3D214%26spage%3D113205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Doyle J.  Cassar</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent inhibitors of the GTPase KRAS
              G12C
              : a review of the patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 103-120. <a href="https://doi.org/10.1080/13543776.2020.1709443" title="DOI URL">https://doi.org/10.1080/13543776.2020.1709443</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1709443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1709443%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DCovalent%252Binhibitors%252Bof%252Bthe%252BGTPase%252BKRAS%252BG12C%252B%25253A%252Ba%252Breview%252Bof%252Bthe%252Bpatent%252Bliterature%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D103%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mossenta</span>, <span class="hlFld-ContribAuthor ">Busato</span>, <span class="hlFld-ContribAuthor ">Baboci</span>, <span class="hlFld-ContribAuthor ">Cintio</span>, <span class="hlFld-ContribAuthor ">Toffoli</span>, <span class="hlFld-ContribAuthor ">Bo</span>. </span><span class="cited-content_cbyCitation_article-title">New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (8)
                                     , 1086. <a href="https://doi.org/10.3390/cancers11081086" title="DOI URL">https://doi.org/10.3390/cancers11081086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11081086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11081086%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNew%252BInsight%252Binto%252BTherapies%252BTargeting%252BAngiogenesis%252Bin%252BHepatocellular%252BCarcinoma%26aulast%3DMossenta%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D8%26spage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hassan  Dianat-Moghadam</span>, <span class="hlFld-ContribAuthor ">Ladan  Teimoori-Toolabi</span>. </span><span class="cited-content_cbyCitation_article-title">Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2019,</strong> <em>20 </em>
                                    (8)
                                     , 852-870. <a href="https://doi.org/10.2174/1389450120666190112145409" title="DOI URL">https://doi.org/10.2174/1389450120666190112145409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450120666190112145409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450120666190112145409%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DImplications%252Bof%252BFibroblast%252BGrowth%252BFactors%252B%252528FGFs%252529%252Bin%252BCancer%25253A%252BFrom%252BPrognostic%252Bto%252BTherapeutic%252BApplications%26aulast%3DDianat-Moghadam%26aufirst%3DHassan%26date%3D2019%26volume%3D20%26issue%3D8%26spage%3D852%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shailima  Rampogu</span>, <span class="hlFld-ContribAuthor ">Ayoung  Baek</span>, <span class="hlFld-ContribAuthor ">Amir  Zeb</span>, <span class="hlFld-ContribAuthor ">Keun Woo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2018,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-018-4050-1" title="DOI URL">https://doi.org/10.1186/s12885-018-4050-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-018-4050-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-018-4050-1%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DExploration%252Bfor%252Bnovel%252Binhibitors%252Bshowing%252Bback-to-front%252Bapproach%252Bagainst%252BVEGFR-2%252Bkinase%252Bdomain%252B%2525284AG8%252529%252Bemploying%252Bmolecular%252Bdocking%252Bmechanism%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DRampogu%26aufirst%3DShailima%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Hao  Qiang</span>, <span class="hlFld-ContribAuthor ">Dandan  Huang</span>, <span class="hlFld-ContribAuthor ">Xinzhou  Bi</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 814-831. <a href="https://doi.org/10.1016/j.ejmech.2018.09.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252Bnovel%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine%252Bderivatives%252Bwith%252Bimproved%252Banticancer%252Befficacy%252Bas%252Bdual%252Binhibitors%252Bof%252Bc-Met%25252FVEGFR-2%26aulast%3DShi%26aufirst%3DWei%26date%3D2018%26volume%3D158%26spage%3D814%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi-fei  Jiang</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Yan-yan  Shen</span>, <span class="hlFld-ContribAuthor ">Yi  Su</span>, <span class="hlFld-ContribAuthor ">Man-man  Wei</span>, <span class="hlFld-ContribAuthor ">Wei-ren  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen-bin  Ding</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying-hong  Shi</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>. </span><span class="cited-content_cbyCitation_article-title">SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2018,</strong> <em>39 </em>
                                    (2)
                                     , 243-250. <a href="https://doi.org/10.1038/aps.2017.96" title="DOI URL">https://doi.org/10.1038/aps.2017.96</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2017.96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2017.96%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DSOMCL-085%25252C%252Ba%252Bnovel%252Bmulti-targeted%252BFGFR%252Binhibitor%25252C%252Bdisplays%252Bpotent%252Banticancer%252Bactivity%252Bin%252BFGFR-addicted%252Bhuman%252Bcancer%252Bmodels%26aulast%3DJiang%26aufirst%3DXi-fei%26date%3D2018%26date%3D2017%26volume%3D39%26issue%3D2%26spage%3D243%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neda  Hashemi-Sadraei</span>, <span class="hlFld-ContribAuthor ">Nasser  Hanna</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting FGFR in Squamous Cell Carcinoma of the Lung. </span><span class="cited-content_cbyCitation_journal-name">Targeted Oncology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (6)
                                     , 741-755. <a href="https://doi.org/10.1007/s11523-017-0513-6" title="DOI URL">https://doi.org/10.1007/s11523-017-0513-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11523-017-0513-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11523-017-0513-6%26sid%3Dliteratum%253Aachs%26jtitle%3DTargeted%2520Oncology%26atitle%3DTargeting%252BFGFR%252Bin%252BSquamous%252BCell%252BCarcinoma%252Bof%252Bthe%252BLung%26aulast%3DHashemi-Sadraei%26aufirst%3DNeda%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D6%26spage%3D741%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stella  Cascioferro</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>. </span><span class="cited-content_cbyCitation_article-title">An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 328-375. <a href="https://doi.org/10.1016/j.ejmech.2017.08.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bon%252Bthe%252Brecent%252Bdevelopments%252Bof%252B1%25252C2%25252C4-triazine%252Bderivatives%252Bas%252Banticancer%252Bcompounds%26aulast%3DCascioferro%26aufirst%3DStella%26date%3D2017%26volume%3D142%26spage%3D328%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jarkko  Rautio</span>, <span class="hlFld-ContribAuthor ">Jussi  Kärkkäinen</span>, <span class="hlFld-ContribAuthor ">Kenneth B.  Sloan</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrugs – Recent approvals and a glimpse of the pipeline. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>109 </em>, 146-161. <a href="https://doi.org/10.1016/j.ejps.2017.08.002" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.08.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.08.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DProdrugs%252B%2525E2%252580%252593%252BRecent%252Bapprovals%252Band%252Ba%252Bglimpse%252Bof%252Bthe%252Bpipeline%26aulast%3DRautio%26aufirst%3DJarkko%26date%3D2017%26volume%3D109%26spage%3D146%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Yanyan  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Yinfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Xu</span>, <span class="hlFld-ContribAuthor ">Mengpeng  Li</span>, <span class="hlFld-ContribAuthor ">Murugavel  Ponnusamy</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Xun  Wang</span>, <span class="hlFld-ContribAuthor ">Pei-Feng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A FGFR1 inhibitor patent review: progress since 2010. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 439-454. <a href="https://doi.org/10.1080/13543776.2017.1272574" title="DOI URL">https://doi.org/10.1080/13543776.2017.1272574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1272574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1272574%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252BFGFR1%252Binhibitor%252Bpatent%252Breview%25253A%252Bprogress%252Bsince%252B2010%26aulast%3DYu%26aufirst%3DTao%26date%3D2017%26date%3D2016%26volume%3D27%26issue%3D4%26spage%3D439%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel  Riechelmann</span>, <span class="hlFld-ContribAuthor ">Axel  Grothey</span>. </span><span class="cited-content_cbyCitation_article-title">Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Medical Oncology</span><span> <strong>2017,</strong> <em>9 </em>
                                    (2)
                                     , 106-126. <a href="https://doi.org/10.1177/1758834016676703" title="DOI URL">https://doi.org/10.1177/1758834016676703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1758834016676703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1758834016676703%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Medical%2520Oncology%26atitle%3DAntiangiogenic%252Btherapy%252Bfor%252Brefractory%252Bcolorectal%252Bcancer%25253A%252Bcurrent%252Boptions%252Band%252Bfuture%252Bstrategies%26aulast%3DRiechelmann%26aufirst%3DRachel%26date%3D2017%26date%3D2016%26volume%3D9%26issue%3D2%26spage%3D106%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">David M.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">Standing on the shoulders of giants: a retrospective analysis of kinase drug discovery at AstraZeneca. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (10)
                                     , 1596-1608. <a href="https://doi.org/10.1016/j.drudis.2016.06.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DStanding%252Bon%252Bthe%252Bshoulders%252Bof%252Bgiants%25253A%252Ba%252Bretrospective%252Banalysis%252Bof%252Bkinase%252Bdrug%252Bdiscovery%252Bat%252BAstraZeneca%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2016%26volume%3D21%26issue%3D10%26spage%3D1596%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokun  Li</span>, <span class="hlFld-ContribAuthor ">Cong  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Xiao</span>, <span class="hlFld-ContribAuthor ">Wallace L.  McKeehan</span>, <span class="hlFld-ContribAuthor ">Fen  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast growth factors, old kids on the new block. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cell & Developmental Biology</span><span> <strong>2016,</strong> <em>53 </em>, 155-167. <a href="https://doi.org/10.1016/j.semcdb.2015.12.014" title="DOI URL">https://doi.org/10.1016/j.semcdb.2015.12.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcdb.2015.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcdb.2015.12.014%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cell%2520%2526%2520Developmental%2520Biology%26atitle%3DFibroblast%252Bgrowth%252Bfactors%25252C%252Bold%252Bkids%252Bon%252Bthe%252Bnew%252Bblock%26aulast%3DLi%26aufirst%3DXiaokun%26date%3D2016%26volume%3D53%26spage%3D155%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akinobu  Taketomi</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical trials of antiangiogenic therapy for hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Clinical Oncology</span><span> <strong>2016,</strong> <em>21 </em>
                                    (2)
                                     , 213-218. <a href="https://doi.org/10.1007/s10147-016-0966-0" title="DOI URL">https://doi.org/10.1007/s10147-016-0966-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10147-016-0966-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10147-016-0966-0%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Clinical%2520Oncology%26atitle%3DClinical%252Btrials%252Bof%252Bantiangiogenic%252Btherapy%252Bfor%252Bhepatocellular%252Bcarcinoma%26aulast%3DTaketomi%26aufirst%3DAkinobu%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D2%26spage%3D213%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Schmidt</span>, <span class="hlFld-ContribAuthor ">Lan  Wei</span>, <span class="hlFld-ContribAuthor ">Danielle K.  DePeralta</span>, <span class="hlFld-ContribAuthor ">Yujin  Hoshida</span>, <span class="hlFld-ContribAuthor ">Poh Seng  Tan</span>, <span class="hlFld-ContribAuthor ">Xiaochen  Sun</span>, <span class="hlFld-ContribAuthor ">Janelle P.  Sventek</span>, <span class="hlFld-ContribAuthor ">Michael  Lanuti</span>, <span class="hlFld-ContribAuthor ">Kenneth K.  Tanabe</span>, <span class="hlFld-ContribAuthor ">Bryan C.  Fuchs</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2016,</strong> <em>138 </em>
                                    (6)
                                     , 1494-1505. <a href="https://doi.org/10.1002/ijc.29893" title="DOI URL">https://doi.org/10.1002/ijc.29893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.29893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.29893%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DMolecular%252Bsubclasses%252Bof%252Bhepatocellular%252Bcarcinoma%252Bpredict%252Bsensitivity%252Bto%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibition%26aulast%3DSchmidt%26aufirst%3DBenjamin%26date%3D2016%26date%3D2015%26volume%3D138%26issue%3D6%26spage%3D1494%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela Cornelia  Lazăr</span>, <span class="hlFld-ContribAuthor ">Sorina  Tăban</span>, <span class="hlFld-ContribAuthor ">Marioara  Cornianu</span>, <span class="hlFld-ContribAuthor ">Alexandra  Faur</span>, <span class="hlFld-ContribAuthor ">Adrian  Goldiş</span>. </span><span class="cited-content_cbyCitation_article-title">New advances in targeted gastric cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Gastroenterology</span><span> <strong>2016,</strong> <em>22 </em>
                                    (30)
                                     , 6776. <a href="https://doi.org/10.3748/wjg.v22.i30.6776" title="DOI URL">https://doi.org/10.3748/wjg.v22.i30.6776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3748/wjg.v22.i30.6776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3748%2Fwjg.v22.i30.6776%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Gastroenterology%26atitle%3DNew%252Badvances%252Bin%252Btargeted%252Bgastric%252Bcancer%252Btreatment%26aulast%3DLaz%25C4%2583r%26aufirst%3DDaniela%2BCornelia%26date%3D2016%26volume%3D22%26issue%3D30%26spage%3D6776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Celina  Ang</span>. </span><span class="cited-content_cbyCitation_article-title">Role of the fibroblast growth factor receptor axis in cholangiocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Gastroenterology and Hepatology</span><span> <strong>2015,</strong> <em>30 </em>
                                    (7)
                                     , 1116-1122. <a href="https://doi.org/10.1111/jgh.12916" title="DOI URL">https://doi.org/10.1111/jgh.12916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jgh.12916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjgh.12916%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Gastroenterology%2520and%2520Hepatology%26atitle%3DRole%252Bof%252Bthe%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252Baxis%252Bin%252Bcholangiocarcinoma%26aulast%3DAng%26aufirst%3DCelina%26date%3D2015%26date%3D2015%26volume%3D30%26issue%3D7%26spage%3D1116%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrice  André</span>, <span class="hlFld-ContribAuthor ">Javier  Cortés</span>. </span><span class="cited-content_cbyCitation_article-title">Rationale for targeting fibroblast growth factor receptor signaling in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2015,</strong> <em>150 </em>
                                    (1)
                                     , 1-8. <a href="https://doi.org/10.1007/s10549-015-3301-y" title="DOI URL">https://doi.org/10.1007/s10549-015-3301-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-015-3301-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-015-3301-y%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DRationale%252Bfor%252Btargeting%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252Bsignaling%252Bin%252Bbreast%252Bcancer%26aulast%3DAndr%25C3%25A9%26aufirst%3DFabrice%26date%3D2015%26date%3D2015%26volume%3D150%26issue%3D1%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Muto</span>, <span class="hlFld-ContribAuthor ">Ken  Shirabe</span>, <span class="hlFld-ContribAuthor ">Keishi  Sugimachi</span>, <span class="hlFld-ContribAuthor ">Yoshihiko  Maehara</span>. </span><span class="cited-content_cbyCitation_article-title">Review of angiogenesis in hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Hepatology Research</span><span> <strong>2015,</strong> <em>45 </em>
                                    (1)
                                     , 1-9. <a href="https://doi.org/10.1111/hepr.12310" title="DOI URL">https://doi.org/10.1111/hepr.12310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/hepr.12310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fhepr.12310%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%2520Research%26atitle%3DReview%252Bof%252Bangiogenesis%252Bin%252Bhepatocellular%252Bcarcinoma%26aulast%3DMuto%26aufirst%3DJun%26date%3D2015%26date%3D2014%26volume%3D45%26issue%3D1%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Camillo  Porta</span>, <span class="hlFld-ContribAuthor ">Palma  Giglione</span>, <span class="hlFld-ContribAuthor ">Wanda  Liguigli</span>, <span class="hlFld-ContribAuthor ">Chiara  Paglino</span>. </span><span class="cited-content_cbyCitation_article-title">Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (1)
                                     , 39-50. <a href="https://doi.org/10.2217/fon.14.208" title="DOI URL">https://doi.org/10.2217/fon.14.208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon.14.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon.14.208%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DDovitinib%252B%252528CHIR258%25252C%252BTKI258%252529%25253A%252Bstructure%25252C%252Bdevelopment%252Band%252Bpreclinical%252Band%252Bclinical%252Bactivity%26aulast%3DPorta%26aufirst%3DCamillo%26date%3D2015%26volume%3D11%26issue%3D1%26spage%3D39%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Bolos</span>, <span class="hlFld-ContribAuthor ">Richard S.  Finn</span>. </span><span class="cited-content_cbyCitation_article-title">Systemic therapy in HCC: Lessons from brivanib. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hepatology</span><span> <strong>2014,</strong> <em>61 </em>
                                    (4)
                                     , 947-950. <a href="https://doi.org/10.1016/j.jhep.2014.06.019" title="DOI URL">https://doi.org/10.1016/j.jhep.2014.06.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jhep.2014.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jhep.2014.06.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hepatology%26atitle%3DSystemic%252Btherapy%252Bin%252BHCC%25253A%252BLessons%252Bfrom%252Bbrivanib%26aulast%3DBolos%26aufirst%3DDavid%26date%3D2014%26volume%3D61%26issue%3D4%26spage%3D947%26epage%3D950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyoung Doo  Song</span>, <span class="hlFld-ContribAuthor ">Dongil  Choi</span>, <span class="hlFld-ContribAuthor ">Jung Hee  Lee</span>, <span class="hlFld-ContribAuthor ">Geun Ho  Im</span>, <span class="hlFld-ContribAuthor ">Jehoon  Yang</span>, <span class="hlFld-ContribAuthor ">Jae-Hun  Kim</span>, <span class="hlFld-ContribAuthor ">Won Jae  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Tumor Microvascular Response to Brivanib by Dynamic Contrast-Enhanced 7-T MRI in an Orthotopic Xenograft Model of Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Roentgenology</span><span> <strong>2014,</strong> <em>202 </em>
                                    (6)
                                     , W559-W566. <a href="https://doi.org/10.2214/AJR.13.11042" title="DOI URL">https://doi.org/10.2214/AJR.13.11042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2214/AJR.13.11042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2214%2FAJR.13.11042%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Roentgenology%26atitle%3DEvaluation%252Bof%252BTumor%252BMicrovascular%252BResponse%252Bto%252BBrivanib%252Bby%252BDynamic%252BContrast-Enhanced%252B7-T%252BMRI%252Bin%252Ban%252BOrthotopic%252BXenograft%252BModel%252Bof%252BHepatocellular%252BCarcinoma%26aulast%3DSong%26aufirst%3DKyoung%2BDoo%26date%3D2014%26volume%3D202%26issue%3D6%26spage%3DW559%26epage%3DW566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ikuo  Nakamura</span>, <span class="hlFld-ContribAuthor ">Kais  Zakharia</span>, <span class="hlFld-ContribAuthor ">Bubu A.  Banini</span>, <span class="hlFld-ContribAuthor ">Dalia S.  Mikhail</span>, <span class="hlFld-ContribAuthor ">Tae Hyo  Kim</span>, <span class="hlFld-ContribAuthor ">Ju Dong  Yang</span>, <span class="hlFld-ContribAuthor ">Catherine D.  Moser</span>, <span class="hlFld-ContribAuthor ">Hassan M.  Shaleh</span>, <span class="hlFld-ContribAuthor ">Sarah R.  Thornburgh</span>, <span class="hlFld-ContribAuthor ">Ian  Walters</span>, <span class="hlFld-ContribAuthor ">Lewis R.  Roberts</span>, . </span><span class="cited-content_cbyCitation_article-title">Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (4)
                                     , e92273. <a href="https://doi.org/10.1371/journal.pone.0092273" title="DOI URL">https://doi.org/10.1371/journal.pone.0092273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0092273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0092273%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DBrivanib%252BAttenuates%252BHepatic%252BFibrosis%252BIn%252BVivo%252Band%252BStellate%252BCell%252BActivation%252BIn%252BVitro%252Bby%252BInhibition%252Bof%252BFGF%25252C%252BVEGF%252Band%252BPDGF%252BSignaling%26aulast%3DNakamura%26aufirst%3DIkuo%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3De92273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Ren-Shyan  Liu</span>, <span class="hlFld-ContribAuthor ">Pei-Chang  Lee</span>, <span class="hlFld-ContribAuthor ">Yi-Chen  Yeh</span>, <span class="hlFld-ContribAuthor ">Yi-Tsau  Huang</span>, <span class="hlFld-ContribAuthor ">Wei-Ping  Lee</span>, <span class="hlFld-ContribAuthor ">Kuei-Chuan  Lee</span>, <span class="hlFld-ContribAuthor ">Yun-Cheng  Hsieh</span>, <span class="hlFld-ContribAuthor ">Fa-Yauh  Lee</span>, <span class="hlFld-ContribAuthor ">Tat-Wei  Tan</span>, <span class="hlFld-ContribAuthor ">Han-Chieh  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat. </span><span class="cited-content_cbyCitation_journal-name">Liver International</span><span> <strong>2014,</strong> <em>34 </em>
                                    (4)
                                     , 521-534. <a href="https://doi.org/10.1111/liv.12299" title="DOI URL">https://doi.org/10.1111/liv.12299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/liv.12299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fliv.12299%26sid%3Dliteratum%253Aachs%26jtitle%3DLiver%2520International%26atitle%3DAnti-VEGFR%252Bagents%252Bameliorate%252Bhepatic%252Bvenous%252Bdysregulation%25252Fmicrocirculatory%252Bdysfunction%25252C%252Bsplanchnic%252Bvenous%252Bpooling%252Band%252Bascites%252Bof%252BNASH-cirrhotic%252Brat%26aulast%3DYang%26aufirst%3DYing-Ying%26date%3D2014%26date%3D2013%26volume%3D34%26issue%3D4%26spage%3D521%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoko  Matsuda</span>, <span class="hlFld-ContribAuthor ">Seiichi  Shinji</span>, <span class="hlFld-ContribAuthor ">Hisashi  Yoshimura</span>, <span class="hlFld-ContribAuthor ">Zenya  Naito</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Ishiwata</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast Growth Factor Receptor-2 IIIc as a Novel Molecular Target in Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Colorectal Cancer Reports</span><span> <strong>2014,</strong> <em>10 </em>
                                    (1)
                                     , 20-26. <a href="https://doi.org/10.1007/s11888-013-0200-7" title="DOI URL">https://doi.org/10.1007/s11888-013-0200-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11888-013-0200-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11888-013-0200-7%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Colorectal%2520Cancer%2520Reports%26atitle%3DFibroblast%252BGrowth%252BFactor%252BReceptor-2%252BIIIc%252Bas%252Ba%252BNovel%252BMolecular%252BTarget%252Bin%252BColorectal%252BCancer%26aulast%3DMatsuda%26aufirst%3DYoko%26date%3D2014%26date%3D2013%26volume%3D10%26issue%3D1%26spage%3D20%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Derek J  Leishman</span>, <span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery vs hERG. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 225-259. <a href="https://doi.org/10.1007/7355_2014_38" title="DOI URL">https://doi.org/10.1007/7355_2014_38</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_38%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BDiscovery%252Bvs%252BhERG%26aulast%3DLeishman%26aufirst%3DDerek%2BJ%26date%3D2014%26date%3D2014%26spage%3D225%26epage%3D259%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">K.  Foote</span>, <span class="hlFld-ContribAuthor ">J.  Kettle</span>, <span class="hlFld-ContribAuthor ">B.  Aquila</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11033-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11033-9%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014%26volume%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Tomao</span>, <span class="hlFld-ContribAuthor ">Anselmo  Papa</span>, <span class="hlFld-ContribAuthor ">Luigi  Rossi</span>, <span class="hlFld-ContribAuthor ">Davide  Caruso</span>, <span class="hlFld-ContribAuthor ">Federica  Zoratto</span>, <span class="hlFld-ContribAuthor ">Pierluigi  Benedetti Panici</span>, <span class="hlFld-ContribAuthor ">Silverio  Tomao</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (1)
                                     , 37-53. <a href="https://doi.org/10.1517/13543784.2013.839657" title="DOI URL">https://doi.org/10.1517/13543784.2013.839657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2013.839657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2013.839657%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DBeyond%252Bbevacizumab%25253A%252Binvestigating%252Bnew%252Bangiogenesis%252Binhibitors%252Bin%252Bovarian%252Bcancer%26aulast%3DTomao%26aufirst%3DFederica%26date%3D2014%26date%3D2013%26volume%3D23%26issue%3D1%26spage%3D37%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruud  van der Noll</span>, <span class="hlFld-ContribAuthor ">Suzanne  Leijen</span>, <span class="hlFld-ContribAuthor ">Guido H.G.  Neuteboom</span>, <span class="hlFld-ContribAuthor ">Jos H.  Beijnen</span>, <span class="hlFld-ContribAuthor ">Jan H.M.  Schellens</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of inhibition of the FGFR–MAPK signaling pathway on the development of ocular toxicities. </span><span class="cited-content_cbyCitation_journal-name">Cancer Treatment Reviews</span><span> <strong>2013,</strong> <em>39 </em>
                                    (6)
                                     , 664-672. <a href="https://doi.org/10.1016/j.ctrv.2013.01.003" title="DOI URL">https://doi.org/10.1016/j.ctrv.2013.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ctrv.2013.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ctrv.2013.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Treatment%2520Reviews%26atitle%3DEffect%252Bof%252Binhibition%252Bof%252Bthe%252BFGFR%2525E2%252580%252593MAPK%252Bsignaling%252Bpathway%252Bon%252Bthe%252Bdevelopment%252Bof%252Bocular%252Btoxicities%26aulast%3Dvan%2Bder%2BNoll%26aufirst%3DRuud%26date%3D2013%26volume%3D39%26issue%3D6%26spage%3D664%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judy W  King</span>, <span class="hlFld-ContribAuthor ">Siow-Ming  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Axitinib for the treatment of advanced non-small-cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2013,</strong> <em>22 </em>
                                    (6)
                                     , 765-773. <a href="https://doi.org/10.1517/13543784.2013.775243" title="DOI URL">https://doi.org/10.1517/13543784.2013.775243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2013.775243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2013.775243%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DAxitinib%252Bfor%252Bthe%252Btreatment%252Bof%252Badvanced%252Bnon-small-cell%252Blung%252Bcancer%26aulast%3DKing%26aufirst%3DJudy%2BW%26date%3D2013%26date%3D2013%26volume%3D22%26issue%3D6%26spage%3D765%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony  El-Khoueiry</span>, <span class="hlFld-ContribAuthor ">James A.  Posey</span>, <span class="hlFld-ContribAuthor ">Juan Ramón  Castillo Ferrando</span>, <span class="hlFld-ContribAuthor ">Smitha S.  Krishnamurthi</span>, <span class="hlFld-ContribAuthor ">Shariq  Syed</span>, <span class="hlFld-ContribAuthor ">Georgia  Kollia</span>, <span class="hlFld-ContribAuthor ">Ian  Walters</span>, <span class="hlFld-ContribAuthor ">Bruce S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>. </span><span class="cited-content_cbyCitation_article-title">The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2013,</strong> <em>72 </em>
                                    (1)
                                     , 53-64. <a href="https://doi.org/10.1007/s00280-013-2168-z" title="DOI URL">https://doi.org/10.1007/s00280-013-2168-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-013-2168-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-013-2168-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DThe%252Beffects%252Bof%252Bliver%252Bimpairment%252Bon%252Bthe%252Bpharmacokinetics%252Bof%252Bbrivanib%25252C%252Ba%252Bdual%252Binhibitor%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252Band%252Bvascular%252Bendothelial%252Bgrowth%252Bfactor%252Breceptor%252Btyrosine%252Bkinases%26aulast%3DEl-Khoueiry%26aufirst%3DAnthony%26date%3D2013%26date%3D2013%26volume%3D72%26issue%3D1%26spage%3D53%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen L.  Richey</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Hutson</span>. </span><span class="cited-content_cbyCitation_article-title">Angiopoietins and Non–Vascular Endothelial Growth Factor Antiangiogenic Targets in Advanced Renal Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">The Cancer Journal</span><span> <strong>2013,</strong> <em>19 </em>
                                    (4)
                                     , 307-310. <a href="https://doi.org/10.1097/PPO.0b013e31829d5d15" title="DOI URL">https://doi.org/10.1097/PPO.0b013e31829d5d15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/PPO.0b013e31829d5d15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FPPO.0b013e31829d5d15%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Cancer%2520Journal%26atitle%3DAngiopoietins%252Band%252BNon%2525E2%252580%252593Vascular%252BEndothelial%252BGrowth%252BFactor%252BAntiangiogenic%252BTargets%252Bin%252BAdvanced%252BRenal%252BCell%252BCarcinoma%26aulast%3DRichey%26aufirst%3DStephen%2BL.%26date%3D2013%26volume%3D19%26issue%3D4%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Vittoria  Dieci</span>, <span class="hlFld-ContribAuthor ">Monica  Arnedos</span>, <span class="hlFld-ContribAuthor ">Fabrice  Andre</span>, <span class="hlFld-ContribAuthor ">Jean Charles  Soria</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2013,</strong> <em>3 </em>
                                    (3)
                                     , 264-279. <a href="https://doi.org/10.1158/2159-8290.CD-12-0362" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-12-0362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-12-0362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-12-0362%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DFibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitors%252Bas%252Ba%252BCancer%252BTreatment%25253A%252BFrom%252Ba%252BBiologic%252BRationale%252Bto%252BMedical%252BPerspectives%26aulast%3DDieci%26aufirst%3DMaria%2BVittoria%26date%3D2013%26date%3D2013%26volume%3D3%26issue%3D3%26spage%3D264%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noriko  Makita</span>, <span class="hlFld-ContribAuthor ">Taroh  Iiri</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase Inhibitor–Induced Thyroid Disorders: A Review and Hypothesis. </span><span class="cited-content_cbyCitation_journal-name">Thyroid</span><span> <strong>2013,</strong> <em>23 </em>
                                    (2)
                                     , 151-159. <a href="https://doi.org/10.1089/thy.2012.0456" title="DOI URL">https://doi.org/10.1089/thy.2012.0456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/thy.2012.0456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fthy.2012.0456%26sid%3Dliteratum%253Aachs%26jtitle%3DThyroid%26atitle%3DTyrosine%252BKinase%252BInhibitor%2525E2%252580%252593Induced%252BThyroid%252BDisorders%25253A%252BA%252BReview%252Band%252BHypothesis%26aulast%3DMakita%26aufirst%3DNoriko%26date%3D2013%26volume%3D23%26issue%3D2%26spage%3D151%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mridul  Roy</span>, <span class="hlFld-ContribAuthor ">Yu-Hao  Luo</span>, <span class="hlFld-ContribAuthor ">Mao  Ye</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Nonsmall Cell Lung Cancer Therapy: Insight into Multitargeted Small-Molecule Growth Factor Receptor Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2013,</strong> <em>2013 </em>, 1-11. <a href="https://doi.org/10.1155/2013/964743" title="DOI URL">https://doi.org/10.1155/2013/964743</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2013/964743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2013%2F964743%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DNonsmall%252BCell%252BLung%252BCancer%252BTherapy%25253A%252BInsight%252Binto%252BMultitargeted%252BSmall-Molecule%252BGrowth%252BFactor%252BReceptor%252BInhibitors%26aulast%3DRoy%26aufirst%3DMridul%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>, <span class="hlFld-ContribAuthor ">Shariq  Syed</span>, <span class="hlFld-ContribAuthor ">Yuan-Qing  Xia</span>, <span class="hlFld-ContribAuthor ">Daphne  Williams</span>, <span class="hlFld-ContribAuthor ">Janice  Pursley</span>, <span class="hlFld-ContribAuthor ">Mohammed  Jemal</span>, <span class="hlFld-ContribAuthor ">W. Griff  Humphreys</span>, <span class="hlFld-ContribAuthor ">Ramaswamy A.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Chiral Inversion of Brivanib and Its Relevance to Safety and Pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2012,</strong> <em>40 </em>
                                    (12)
                                     , 2374-2380. <a href="https://doi.org/10.1124/dmd.112.047340" title="DOI URL">https://doi.org/10.1124/dmd.112.047340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.112.047340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.112.047340%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolic%252BChiral%252BInversion%252Bof%252BBrivanib%252Band%252BIts%252BRelevance%252Bto%252BSafety%252Band%252BPharmacology%26aulast%3DGong%26aufirst%3DJiachang%26date%3D2012%26date%3D2012%26volume%3D40%26issue%3D12%26spage%3D2374%26epage%3D2380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter M.  Ellis</span>, <span class="hlFld-ContribAuthor ">Khalid  Al-Saleh</span>. </span><span class="cited-content_cbyCitation_article-title">Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Oncology/Hematology</span><span> <strong>2012,</strong> <em>84 </em>
                                    (1)
                                     , 47-58. <a href="https://doi.org/10.1016/j.critrevonc.2012.02.004" title="DOI URL">https://doi.org/10.1016/j.critrevonc.2012.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.critrevonc.2012.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.critrevonc.2012.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Oncology%252FHematology%26atitle%3DMultitargeted%252Banti-angiogenic%252Bagents%252Band%252BNSCLC%25253A%252BClinical%252Bupdate%252Band%252Bfuture%252Bdirections%26aulast%3DEllis%26aufirst%3DPeter%2BM.%26date%3D2012%26volume%3D84%26issue%3D1%26spage%3D47%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang  Liang</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>, <span class="hlFld-ContribAuthor ">Yuepiao  Cai</span>, <span class="hlFld-ContribAuthor ">Xiaokun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer molecules targeting fibroblast growth factor receptors. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2012,</strong> <em>33 </em>
                                    (10)
                                     , 531-541. <a href="https://doi.org/10.1016/j.tips.2012.07.001" title="DOI URL">https://doi.org/10.1016/j.tips.2012.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2012.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DAnticancer%252Bmolecules%252Btargeting%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptors%26aulast%3DLiang%26aufirst%3DGuang%26date%3D2012%26volume%3D33%26issue%3D10%26spage%3D531%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tina  Chou</span>, <span class="hlFld-ContribAuthor ">Richard S  Finn</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib: a review of development. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2012,</strong> <em>8 </em>
                                    (9)
                                     , 1083-1090. <a href="https://doi.org/10.2217/fon.12.104" title="DOI URL">https://doi.org/10.2217/fon.12.104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon.12.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon.12.104%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DBrivanib%25253A%252Ba%252Breview%252Bof%252Bdevelopment%26aulast%3DChou%26aufirst%3DTina%26date%3D2012%26volume%3D8%26issue%3D9%26spage%3D1083%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingyi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Bai</span>, <span class="hlFld-ContribAuthor ">Rui  Xie</span>, <span class="hlFld-ContribAuthor ">Liping  Sun</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and strategies of VEGFR-2/KDR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (14)
                                     , 1839-1852. <a href="https://doi.org/10.4155/fmc.12.121" title="DOI URL">https://doi.org/10.4155/fmc.12.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.121%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bstrategies%252Bof%252BVEGFR-2%25252FKDR%252Binhibitors%26aulast%3DHuang%26aufirst%3DLingyi%26date%3D2012%26volume%3D4%26issue%3D14%26spage%3D1839%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joost CM  Uitdehaag</span>, <span class="hlFld-ContribAuthor ">Folkert  Verkaar</span>, <span class="hlFld-ContribAuthor ">Husam  Alwan</span>, <span class="hlFld-ContribAuthor ">Jos  de Man</span>, <span class="hlFld-ContribAuthor ">Rogier C  Buijsman</span>, <span class="hlFld-ContribAuthor ">Guido JR  Zaman</span>. </span><span class="cited-content_cbyCitation_article-title">A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2012,</strong> <em>166 </em>
                                    (3)
                                     , 858-876. <a href="https://doi.org/10.1111/j.1476-5381.2012.01859.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2012.01859.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2012.01859.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2012.01859.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DA%252Bguide%252Bto%252Bpicking%252Bthe%252Bmost%252Bselective%252Bkinase%252Binhibitor%252Btool%252Bcompounds%252Bfor%252Bpharmacological%252Bvalidation%252Bof%252Bdrug%252Btargets%26aulast%3DUitdehaag%26aufirst%3DJoost%2BCM%26date%3D2012%26date%3D2012%26volume%3D166%26issue%3D3%26spage%3D858%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas J.  Semrad</span>, <span class="hlFld-ContribAuthor ">Philip C.  Mack</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast Growth Factor Signaling in Non–Small-Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Lung Cancer</span><span> <strong>2012,</strong> <em>13 </em>
                                    (2)
                                     , 90-95. <a href="https://doi.org/10.1016/j.cllc.2011.08.001" title="DOI URL">https://doi.org/10.1016/j.cllc.2011.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cllc.2011.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cllc.2011.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Lung%2520Cancer%26atitle%3DFibroblast%252BGrowth%252BFactor%252BSignaling%252Bin%252BNon%2525E2%252580%252593Small-Cell%252BLung%252BCancer%26aulast%3DSemrad%26aufirst%3DThomas%2BJ.%26date%3D2012%26volume%3D13%26issue%3D2%26spage%3D90%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph M.  Gozgit</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Wong</span>, <span class="hlFld-ContribAuthor ">Lauren  Moran</span>, <span class="hlFld-ContribAuthor ">Scott  Wardwell</span>, <span class="hlFld-ContribAuthor ">Qurish K.  Mohemmad</span>, <span class="hlFld-ContribAuthor ">Narayana I.  Narasimhan</span>, <span class="hlFld-ContribAuthor ">William C.  Shakespeare</span>, <span class="hlFld-ContribAuthor ">Frank  Wang</span>, <span class="hlFld-ContribAuthor ">Tim  Clackson</span>, <span class="hlFld-ContribAuthor ">Victor M.  Rivera</span>. </span><span class="cited-content_cbyCitation_article-title">Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2012,</strong> <em>11 </em>
                                    (3)
                                     , 690-699. <a href="https://doi.org/10.1158/1535-7163.MCT-11-0450" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-11-0450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-11-0450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-11-0450%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DPonatinib%252B%252528AP24534%252529%25252C%252Ba%252BMultitargeted%252BPan-FGFR%252BInhibitor%252Bwith%252BActivity%252Bin%252BMultiple%252BFGFR-Amplified%252Bor%252BMutated%252BCancer%252BModels%26aulast%3DGozgit%26aufirst%3DJoseph%2BM.%26date%3D2012%26date%3D2012%26volume%3D11%26issue%3D3%26spage%3D690%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Lance  Cowey</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Hutson</span>. </span><span class="cited-content_cbyCitation_article-title">Angiopoietins and Other Non-VEGF Antiangiogenic Targets in Advanced Renal Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 135-160. <a href="https://doi.org/10.1007/978-1-4614-2400-0_7" title="DOI URL">https://doi.org/10.1007/978-1-4614-2400-0_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-2400-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-2400-0_7%26sid%3Dliteratum%253Aachs%26atitle%3DAngiopoietins%252Band%252BOther%252BNon-VEGF%252BAntiangiogenic%252BTargets%252Bin%252BAdvanced%252BRenal%252BCell%252BCarcinoma%26aulast%3DCowey%26aufirst%3DC.%2BLance%26date%3D2012%26date%3D2012%26spage%3D135%26epage%3D160%26pub%3DSpringer%2520US%26atitle%3DRenal%252BCell%252BCarcinoma%26aulast%3DFiglin%26aufirst%3DRobert%2BA.%26date%3D2012%26volume%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.F.  Larrow</span>, <span class="hlFld-ContribAuthor ">P.F.  Quigley</span>. </span><span class="cited-content_cbyCitation_article-title">9.7 Industrial Applications of the Jacobsen Hydrolytic Kinetic Resolution Technology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 129-146. <a href="https://doi.org/10.1016/B978-0-08-095167-6.00910-1" title="DOI URL">https://doi.org/10.1016/B978-0-08-095167-6.00910-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-095167-6.00910-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-095167-6.00910-1%26sid%3Dliteratum%253Aachs%26atitle%3D9.7%252BIndustrial%252BApplications%252Bof%252Bthe%252BJacobsen%252BHydrolytic%252BKinetic%252BResolution%252BTechnology%26aulast%3DLarrow%26aufirst%3DJ.F.%26date%3D2012%26spage%3D129%26epage%3D146%26pub%3DElsevier%26atitle%3DComprehensive%252BChirality%26date%3D2012%26volume%3DVol.%252014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Ramaswamy A.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the Oxidative and Conjugative Enzymes Involved in the Biotransformation of Brivanib. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2012,</strong> <em>40 </em>
                                    (1)
                                     , 219-226. <a href="https://doi.org/10.1124/dmd.111.042457" title="DOI URL">https://doi.org/10.1124/dmd.111.042457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.111.042457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.111.042457%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DIdentification%252Bof%252Bthe%252BOxidative%252Band%252BConjugative%252BEnzymes%252BInvolved%252Bin%252Bthe%252BBiotransformation%252Bof%252BBrivanib%26aulast%3DGong%26aufirst%3DJiachang%26date%3D2012%26date%3D2011%26volume%3D40%26issue%3D1%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia  LoRusso</span>, <span class="hlFld-ContribAuthor ">Geoffrey I.  Shapiro</span>, <span class="hlFld-ContribAuthor ">Herbert  Hurwitz</span>, <span class="hlFld-ContribAuthor ">Mary Jo  Pilat</span>, <span class="hlFld-ContribAuthor ">Janice  Chemidlin</span>, <span class="hlFld-ContribAuthor ">Georgia  Kollia</span>, <span class="hlFld-ContribAuthor ">Shariq  Syed</span>, <span class="hlFld-ContribAuthor ">Bruce  Fischer</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>. </span><span class="cited-content_cbyCitation_article-title">Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumors. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2011,</strong> <em>68 </em>
                                    (6)
                                     , 1377-1385. <a href="https://doi.org/10.1007/s00280-011-1603-2" title="DOI URL">https://doi.org/10.1007/s00280-011-1603-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-011-1603-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-011-1603-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DLack%252Bof%252Bfood%252Beffect%252Bon%252Bsingle-dose%252Bpharmacokinetics%252Bof%252Bbrivanib%25252C%252Band%252Bsafety%252Band%252Befficacy%252Bfollowing%252Bmultiple%252Bdoses%252Bin%252Bsubjects%252Bwith%252Badvanced%252Bor%252Bmetastatic%252Bsolid%252Btumors%26aulast%3DLoRusso%26aufirst%3DPatricia%26date%3D2011%26date%3D2011%26volume%3D68%26issue%3D6%26spage%3D1377%26epage%3D1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A.  Socinski</span>. </span><span class="cited-content_cbyCitation_article-title">Multitargeted receptor tyrosine kinase inhibition: An antiangiogenic strategy in non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Treatment Reviews</span><span> <strong>2011,</strong> <em>37 </em>
                                    (8)
                                     , 611-617. <a href="https://doi.org/10.1016/j.ctrv.2011.04.003" title="DOI URL">https://doi.org/10.1016/j.ctrv.2011.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ctrv.2011.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ctrv.2011.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Treatment%2520Reviews%26atitle%3DMultitargeted%252Breceptor%252Btyrosine%252Bkinase%252Binhibition%25253A%252BAn%252Bantiangiogenic%252Bstrategy%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DSocinski%26aufirst%3DMark%2BA.%26date%3D2011%26volume%3D37%26issue%3D8%26spage%3D611%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Heinzle</span>, <span class="hlFld-ContribAuthor ">Hedwig  Sutterlüty</span>, <span class="hlFld-ContribAuthor ">Michael  Grusch</span>, <span class="hlFld-ContribAuthor ">Bettina  Grasl-Kraupp</span>, <span class="hlFld-ContribAuthor ">Walter  Berger</span>, <span class="hlFld-ContribAuthor ">Brigitte  Marian</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2011,</strong> <em>15 </em>
                                    (7)
                                     , 829-846. <a href="https://doi.org/10.1517/14728222.2011.566217" title="DOI URL">https://doi.org/10.1517/14728222.2011.566217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2011.566217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2011.566217%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252Bfibroblast-growth-factor-receptor-dependent%252Bsignaling%252Bfor%252Bcancer%252Btherapy%26aulast%3DHeinzle%26aufirst%3DChristine%26date%3D2011%26date%3D2011%26volume%3D15%26issue%3D7%26spage%3D829%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C R  Garrett</span>, <span class="hlFld-ContribAuthor ">L L  Siu</span>, <span class="hlFld-ContribAuthor ">A  El-Khoueiry</span>, <span class="hlFld-ContribAuthor ">J  Buter</span>, <span class="hlFld-ContribAuthor ">C M  Rocha-Lima</span>, <span class="hlFld-ContribAuthor ">J  Marshall</span>, <span class="hlFld-ContribAuthor ">P  LoRusso</span>, <span class="hlFld-ContribAuthor ">P  Major</span>, <span class="hlFld-ContribAuthor ">J  Chemidlin</span>, <span class="hlFld-ContribAuthor ">O  Mokliatchouk</span>, <span class="hlFld-ContribAuthor ">L  Velasquez</span>, <span class="hlFld-ContribAuthor ">W  Hayes</span>, <span class="hlFld-ContribAuthor ">D  Feltquate</span>, <span class="hlFld-ContribAuthor ">S  Syed</span>, <span class="hlFld-ContribAuthor ">S  Ford</span>, <span class="hlFld-ContribAuthor ">G  Kollia</span>, <span class="hlFld-ContribAuthor ">S  Galbraith</span>, <span class="hlFld-ContribAuthor ">D S A  Nuyten</span>. </span><span class="cited-content_cbyCitation_article-title">Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2011,</strong> <em>105 </em>
                                    (1)
                                     , 44-52. <a href="https://doi.org/10.1038/bjc.2011.182" title="DOI URL">https://doi.org/10.1038/bjc.2011.182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/bjc.2011.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fbjc.2011.182%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DPhase%252BI%252Bdose-escalation%252Bstudy%252Bto%252Bdetermine%252Bthe%252Bsafety%25252C%252Bpharmacokinetics%252Band%252Bpharmacodynamics%252Bof%252Bbrivanib%252Balaninate%252Bin%252Bcombination%252Bwith%252Bfull-dose%252Bcetuximab%252Bin%252Bpatients%252Bwith%252Badvanced%252Bgastrointestinal%252Bmalignancies%252Bwho%252Bhave%252Bfailed%252Bprior%252Btherapy%26aulast%3DGarrett%26aufirst%3DC%2BR%26date%3D2011%26date%3D2011%26volume%3D105%26issue%3D1%26spage%3D44%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.J.  Jonker</span>, <span class="hlFld-ContribAuthor ">L.S.  Rosen</span>, <span class="hlFld-ContribAuthor ">M.B.  Sawyer</span>, <span class="hlFld-ContribAuthor ">F.  de Braud</span>, <span class="hlFld-ContribAuthor ">G.  Wilding</span>, <span class="hlFld-ContribAuthor ">C.J.  Sweeney</span>, <span class="hlFld-ContribAuthor ">G.C.  Jayson</span>, <span class="hlFld-ContribAuthor ">G.A.  McArthur</span>, <span class="hlFld-ContribAuthor ">G.  Rustin</span>, <span class="hlFld-ContribAuthor ">G.  Goss</span>, <span class="hlFld-ContribAuthor ">J.  Kantor</span>, <span class="hlFld-ContribAuthor ">L.  Velasquez</span>, <span class="hlFld-ContribAuthor ">S.  Syed</span>, <span class="hlFld-ContribAuthor ">O.  Mokliatchouk</span>, <span class="hlFld-ContribAuthor ">D.M.  Feltquate</span>, <span class="hlFld-ContribAuthor ">G.  Kollia</span>, <span class="hlFld-ContribAuthor ">D.S.A.  Nuyten</span>, <span class="hlFld-ContribAuthor ">S.  Galbraith</span>. </span><span class="cited-content_cbyCitation_article-title">A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors. </span><span class="cited-content_cbyCitation_journal-name">Annals of Oncology</span><span> <strong>2011,</strong> <em>22 </em>
                                    (6)
                                     , 1413-1419. <a href="https://doi.org/10.1093/annonc/mdq599" title="DOI URL">https://doi.org/10.1093/annonc/mdq599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/annonc/mdq599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fannonc%2Fmdq599%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Oncology%26atitle%3DA%252Bphase%252BI%252Bstudy%252Bto%252Bdetermine%252Bthe%252Bsafety%25252C%252Bpharmacokinetics%252Band%252Bpharmacodynamics%252Bof%252Ba%252Bdual%252BVEGFR%252Band%252BFGFR%252Binhibitor%25252C%252Bbrivanib%25252C%252Bin%252Bpatients%252Bwith%252Badvanced%252Bor%252Bmetastatic%252Bsolid%252Btumors%26aulast%3DJonker%26aufirst%3DD.J.%26date%3D2011%26volume%3D22%26issue%3D6%26spage%3D1413%26epage%3D1419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott B.  Tran</span>, <span class="hlFld-ContribAuthor ">Michael W.  Lago</span>, <span class="hlFld-ContribAuthor ">Yuan  Tian</span>, <span class="hlFld-ContribAuthor ">Sharon X.  Gong</span>, <span class="hlFld-ContribAuthor ">Indu  Batra</span>, <span class="hlFld-ContribAuthor ">Alban J.  Allentoff</span>, <span class="hlFld-ContribAuthor ">Brad D.  Maxwell</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Bonacorsi</span>, <span class="hlFld-ContribAuthor ">Marc  Ogan</span>, <span class="hlFld-ContribAuthor ">J. Kent  Rinehart</span>, <span class="hlFld-ContribAuthor ">Balu  Balasubramanian</span>. </span><span class="cited-content_cbyCitation_article-title">The 14C, 13C, and 15N syntheses of a potent VEGFR-2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2011,</strong> <em>54 </em>
                                    (6)
                                     , 324-331. <a href="https://doi.org/10.1002/jlcr.1871" title="DOI URL">https://doi.org/10.1002/jlcr.1871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.1871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.1871%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DThe%252B14C%25252C%252B13C%25252C%252Band%252B15N%252Bsyntheses%252Bof%252Ba%252Bpotent%252BVEGFR-2%252Bkinase%252Binhibitor%25252C%252BBrivanib%25252C%252Band%252Bits%252Bprodrug%25252C%252BBrivanib%252BAlaninate%26aulast%3DTran%26aufirst%3DScott%2BB.%26date%3D2011%26date%3D2011%26volume%3D54%26issue%3D6%26spage%3D324%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Janet  Caceres-Cortes</span>, <span class="hlFld-ContribAuthor ">Lisa J.  Christopher</span>, <span class="hlFld-ContribAuthor ">Vinod  Arora</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>, <span class="hlFld-ContribAuthor ">Daphne  Williams</span>, <span class="hlFld-ContribAuthor ">Janice  Pursley</span>, <span class="hlFld-ContribAuthor ">Alban  Allentoff</span>, <span class="hlFld-ContribAuthor ">Michael  Lago</span>, <span class="hlFld-ContribAuthor ">Scott B.  Tran</span>, <span class="hlFld-ContribAuthor ">Ramaswamy A.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism and Disposition of [
              14
              C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2011,</strong> <em>39 </em>
                                    (5)
                                     , 891-903. <a href="https://doi.org/10.1124/dmd.110.037341" title="DOI URL">https://doi.org/10.1124/dmd.110.037341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.110.037341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.110.037341%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolism%252Band%252BDisposition%252Bof%252B%25255B%252B14%252BC%25255DBrivanib%252BAlaninate%252Bafter%252BOral%252BAdministration%252Bto%252BRats%25252C%252BMonkeys%25252C%252Band%252BHumans%26aulast%3DGong%26aufirst%3DJiachang%26date%3D2011%26date%3D2011%26volume%3D39%26issue%3D5%26spage%3D891%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joong-Won  Park</span>, <span class="hlFld-ContribAuthor ">Richard S.  Finn</span>, <span class="hlFld-ContribAuthor ">Jun Suk  Kim</span>, <span class="hlFld-ContribAuthor ">Mark  Karwal</span>, <span class="hlFld-ContribAuthor ">Ruby K.  Li</span>, <span class="hlFld-ContribAuthor ">Fuad  Ismail</span>, <span class="hlFld-ContribAuthor ">Melanie  Thomas</span>, <span class="hlFld-ContribAuthor ">Rosemarie  Harris</span>, <span class="hlFld-ContribAuthor ">Christine  Baudelet</span>, <span class="hlFld-ContribAuthor ">Ian  Walters</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Raoul</span>. </span><span class="cited-content_cbyCitation_article-title">Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2011,</strong> <em>17 </em>
                                    (7)
                                     , 1973-1983. <a href="https://doi.org/10.1158/1078-0432.CCR-10-2011" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-10-2011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-10-2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-10-2011%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DPhase%252BII%25252C%252BOpen-Label%252BStudy%252Bof%252BBrivanib%252Bas%252BFirst-Line%252BTherapy%252Bin%252BPatients%252Bwith%252BAdvanced%252BHepatocellular%252BCarcinoma%26aulast%3DPark%26aufirst%3DJoong-Won%26date%3D2011%26date%3D2011%26volume%3D17%26issue%3D7%26spage%3D1973%26epage%3D1983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivan  Diaz-Padilla</span>, <span class="hlFld-ContribAuthor ">Lillian L  Siu</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib alaninate for cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2011,</strong> <em>20 </em>
                                    (4)
                                     , 577-586. <a href="https://doi.org/10.1517/13543784.2011.565329" title="DOI URL">https://doi.org/10.1517/13543784.2011.565329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2011.565329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2011.565329%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DBrivanib%252Balaninate%252Bfor%252Bcancer%26aulast%3DDiaz-Padilla%26aufirst%3DIvan%26date%3D2011%26date%3D2011%26volume%3D20%26issue%3D4%26spage%3D577%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenji  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Fumiaki  Ito</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor Tyrosine Kinases and Targeted Cancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Biological and Pharmaceutical Bulletin</span><span> <strong>2011,</strong> <em>34 </em>
                                    (12)
                                     , 1774-1780. <a href="https://doi.org/10.1248/bpb.34.1774" title="DOI URL">https://doi.org/10.1248/bpb.34.1774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/bpb.34.1774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fbpb.34.1774%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DReceptor%252BTyrosine%252BKinases%252Band%252BTargeted%252BCancer%252BTherapeutics%26aulast%3DTakeuchi%26aufirst%3DKenji%26date%3D2011%26volume%3D34%26issue%3D12%26spage%3D1774%26epage%3D1780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heesue  Kim</span>, <span class="hlFld-ContribAuthor ">Ho Yeong  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Novel EGFR-TK Inhibitor EKB-569 Inhibits Hepatocellular Carcinoma Cell Proliferation by AKT and MAPK Pathways. </span><span class="cited-content_cbyCitation_journal-name">Journal of Korean Medical Science</span><span> <strong>2011,</strong> <em>26 </em>
                                    (12)
                                     , 1563. <a href="https://doi.org/10.3346/jkms.2011.26.12.1563" title="DOI URL">https://doi.org/10.3346/jkms.2011.26.12.1563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3346/jkms.2011.26.12.1563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3346%2Fjkms.2011.26.12.1563%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Korean%2520Medical%2520Science%26atitle%3DNovel%252BEGFR-TK%252BInhibitor%252BEKB-569%252BInhibits%252BHepatocellular%252BCarcinoma%252BCell%252BProliferation%252Bby%252BAKT%252Band%252BMAPK%252BPathways%26aulast%3DKim%26aufirst%3DHeesue%26date%3D2011%26volume%3D26%26issue%3D12%26spage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarek  Mekhail</span>, <span class="hlFld-ContribAuthor ">Eric  Masson</span>, <span class="hlFld-ContribAuthor ">Bruce S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Jiachang  Gong</span>, <span class="hlFld-ContribAuthor ">Ramaswamy  Iyer</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Janice  Pursley</span>, <span class="hlFld-ContribAuthor ">Daniel  Patricia</span>, <span class="hlFld-ContribAuthor ">Daphne  Williams</span>, <span class="hlFld-ContribAuthor ">Ram  Ganapathi</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism, Excretion, and Pharmacokinetics of Oral Brivanib in Patients with Advanced or Metastatic Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2010,</strong> <em>38 </em>
                                    (11)
                                     , 1962-1966. <a href="https://doi.org/10.1124/dmd.110.033951" title="DOI URL">https://doi.org/10.1124/dmd.110.033951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.110.033951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.110.033951%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMetabolism%25252C%252BExcretion%25252C%252Band%252BPharmacokinetics%252Bof%252BOral%252BBrivanib%252Bin%252BPatients%252Bwith%252BAdvanced%252Bor%252BMetastatic%252BSolid%252BTumors%26aulast%3DMekhail%26aufirst%3DTarek%26date%3D2010%26date%3D2010%26volume%3D38%26issue%3D11%26spage%3D1962%26epage%3D1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine Y.  Shiang</span>, <span class="hlFld-ContribAuthor ">Yuan  Qi</span>, <span class="hlFld-ContribAuthor ">Bailiang  Wang</span>, <span class="hlFld-ContribAuthor ">Vladimir  Lazar</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">W.  Fraser Symmans</span>, <span class="hlFld-ContribAuthor ">Gabriel N.  Hortobagyi</span>, <span class="hlFld-ContribAuthor ">Fabrice  Andre</span>, <span class="hlFld-ContribAuthor ">Lajos  Pusztai</span>. </span><span class="cited-content_cbyCitation_article-title">Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2010,</strong> <em>123 </em>
                                    (3)
                                     , 747-755. <a href="https://doi.org/10.1007/s10549-009-0677-6" title="DOI URL">https://doi.org/10.1007/s10549-009-0677-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-009-0677-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-009-0677-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DAmplification%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor-1%252Bin%252Bbreast%252Bcancer%252Band%252Bthe%252Beffects%252Bof%252Bbrivanib%252Balaninate%26aulast%3DShiang%26aufirst%3DChristine%2BY.%26date%3D2010%26date%3D2009%26volume%3D123%26issue%3D3%26spage%3D747%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert H.  Bradbury</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors: Approved Drugs and Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 295-344. <a href="https://doi.org/10.1002/0471266949.bmc214" title="DOI URL">https://doi.org/10.1002/0471266949.bmc214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc214%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%25253A%252BApproved%252BDrugs%252Band%252BClinical%252BCandidates%26aulast%3DBradbury%26aufirst%3DRobert%2BH.%26date%3D2010%26date%3D2010%26spage%3D295%26epage%3D344%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huahui  Zeng</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2010,</strong> <em>29 </em>
                                    (1)
                                     , 54-71. <a href="https://doi.org/10.1016/j.jmgm.2010.04.004" title="DOI URL">https://doi.org/10.1016/j.jmgm.2010.04.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2010.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2010.04.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DCombined%252B3D-QSAR%252Bmodeling%252Band%252Bmolecular%252Bdocking%252Bstudy%252Bon%252B1%25252C4-dihydroindeno%25255B1%25252C2-c%25255Dpyrazoles%252Bas%252BVEGFR-2%252Bkinase%252Binhibitors%26aulast%3DZeng%26aufirst%3DHuahui%26date%3D2010%26volume%3D29%26issue%3D1%26spage%3D54%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roshani R.  Patel</span>, <span class="hlFld-ContribAuthor ">Surojeet  Sengupta</span>, <span class="hlFld-ContribAuthor ">Helen R.  Kim</span>, <span class="hlFld-ContribAuthor ">Andres J.  Klein-Szanto</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Pyle</span>, <span class="hlFld-ContribAuthor ">Fang  Zhu</span>, <span class="hlFld-ContribAuthor ">Tianyu  Li</span>, <span class="hlFld-ContribAuthor ">Eric A.  Ross</span>, <span class="hlFld-ContribAuthor ">Salewa  Oseni</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">V. Craig  Jordan</span>. </span><span class="cited-content_cbyCitation_article-title">Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: A potential clinical application of angiogenesis inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Cancer</span><span> <strong>2010,</strong> <em>46 </em>
                                    (9)
                                     , 1537-1553. <a href="https://doi.org/10.1016/j.ejca.2010.02.018" title="DOI URL">https://doi.org/10.1016/j.ejca.2010.02.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejca.2010.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejca.2010.02.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Cancer%26atitle%3DExperimental%252Btreatment%252Bof%252Boestrogen%252Breceptor%252B%252528ER%252529%252Bpositive%252Bbreast%252Bcancer%252Bwith%252Btamoxifen%252Band%252Bbrivanib%252Balaninate%25252C%252Ba%252BVEGFR-2%25252FFGFR-1%252Bkinase%252Binhibitor%25253A%252BA%252Bpotential%252Bclinical%252Bapplication%252Bof%252Bangiogenesis%252Binhibitors%26aulast%3DPatel%26aufirst%3DRoshani%2BR.%26date%3D2010%26volume%3D46%26issue%3D9%26spage%3D1537%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hung  Huynh</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine kinase inhibitors to treat liver cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2010,</strong> <em>15 </em>
                                    (1)
                                     , 13-26. <a href="https://doi.org/10.1517/14728210903571659" title="DOI URL">https://doi.org/10.1517/14728210903571659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728210903571659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728210903571659%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DTyrosine%252Bkinase%252Binhibitors%252Bto%252Btreat%252Bliver%252Bcancer%26aulast%3DHuynh%26aufirst%3DHung%26date%3D2010%26date%3D2010%26volume%3D15%26issue%3D1%26spage%3D13%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Zhen-wei  Cai</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Susan  Galbraith</span>, <span class="hlFld-ContribAuthor ">Robert  Jeyaseelan</span>, <span class="hlFld-ContribAuthor ">Steven  Mortillo</span>, <span class="hlFld-ContribAuthor ">Barri S.  Wautlet</span>, <span class="hlFld-ContribAuthor ">Bala  Krishnan</span>, <span class="hlFld-ContribAuthor ">Daniel  Kukral</span>, <span class="hlFld-ContribAuthor ">Harold  Malone</span>, <span class="hlFld-ContribAuthor ">Anne C.  Lewin</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Henley</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>. </span><span class="cited-content_cbyCitation_article-title">The Antiangiogenic Activity in Xenograft Models of Brivanib, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinases. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2010,</strong> <em>9 </em>
                                    (2)
                                     , 369-378. <a href="https://doi.org/10.1158/1535-7163.MCT-09-0472" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-09-0472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-09-0472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-09-0472%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DThe%252BAntiangiogenic%252BActivity%252Bin%252BXenograft%252BModels%252Bof%252BBrivanib%25252C%252Ba%252BDual%252BInhibitor%252Bof%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor-2%252Band%252BFibroblast%252BGrowth%252BFactor%252BReceptor-1%252BKinases%26aulast%3DBhide%26aufirst%3DRajeev%2BS.%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D2%26spage%3D369%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Amrita V.  Kamath</span>, <span class="hlFld-ContribAuthor ">Yueping  Zhang</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Rajeev  Bhide</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2009,</strong> <em>65 </em>
                                    (1)
                                     , 55-66. <a href="https://doi.org/10.1007/s00280-009-1002-0" title="DOI URL">https://doi.org/10.1007/s00280-009-1002-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-009-1002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-009-1002-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DPreclinical%252Bpharmacokinetics%252Band%252Bin%252Bvitro%252Bmetabolism%252Bof%252Bbrivanib%252B%252528BMS-540215%252529%25252C%252Ba%252Bpotent%252BVEGFR2%252Binhibitor%252Band%252Bits%252Balanine%252Bester%252Bprodrug%252Bbrivanib%252Balaninate%26aulast%3DMarathe%26aufirst%3DPunit%2BH.%26date%3D2009%26date%3D2009%26volume%3D65%26issue%3D1%26spage%3D55%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy  Coon</span>, <span class="hlFld-ContribAuthor ">Wilna J.  Moree</span>, <span class="hlFld-ContribAuthor ">Binfeng  Li</span>, <span class="hlFld-ContribAuthor ">Jinghua  Yu</span>, <span class="hlFld-ContribAuthor ">Said  Zamani-Kord</span>, <span class="hlFld-ContribAuthor ">Siobhan  Malany</span>, <span class="hlFld-ContribAuthor ">Mark A.  Santos</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Hernandez</span>, <span class="hlFld-ContribAuthor ">Robert E.  Petroski</span>, <span class="hlFld-ContribAuthor ">Aixia  Sun</span>, <span class="hlFld-ContribAuthor ">Jenny  Wen</span>, <span class="hlFld-ContribAuthor ">Sue  Sullivan</span>, <span class="hlFld-ContribAuthor ">Jason  Haelewyn</span>, <span class="hlFld-ContribAuthor ">Michael  Hedrick</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Hoare</span>, <span class="hlFld-ContribAuthor ">Margaret J.  Bradbury</span>, <span class="hlFld-ContribAuthor ">Paul D.  Crowe</span>, <span class="hlFld-ContribAuthor ">Graham  Beaton</span>. </span><span class="cited-content_cbyCitation_article-title">Brain-penetrating 2-aminobenzimidazole H1-antihistamines for the treatment of insomnia. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (15)
                                     , 4380-4384. <a href="https://doi.org/10.1016/j.bmcl.2009.05.086" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.05.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.05.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.05.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBrain-penetrating%252B2-aminobenzimidazole%252BH1-antihistamines%252Bfor%252Bthe%252Btreatment%252Bof%252Binsomnia%26aulast%3DCoon%26aufirst%3DTimothy%26date%3D2009%26volume%3D19%26issue%3D15%26spage%3D4380%26epage%3D4384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott A.  Kono</span>, <span class="hlFld-ContribAuthor ">Marianne E.  Marshall</span>, <span class="hlFld-ContribAuthor ">Kathryn E.  Ware</span>, <span class="hlFld-ContribAuthor ">Lynn E.  Heasley</span>. </span><span class="cited-content_cbyCitation_article-title">The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2009,</strong> <em>12 </em>
                                    (4-5)
                                     , 95-102. <a href="https://doi.org/10.1016/j.drup.2009.05.001" title="DOI URL">https://doi.org/10.1016/j.drup.2009.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2009.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2009.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DThe%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252Bsignaling%252Bpathway%252Bas%252Ba%252Bmediator%252Bof%252Bintrinsic%252Bresistance%252Bto%252BEGFR-specific%252Btyrosine%252Bkinase%252Binhibitors%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DKono%26aufirst%3DScott%2BA.%26date%3D2009%26volume%3D12%26issue%3D4-5%26spage%3D95%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robin K.  Kelley</span>, <span class="hlFld-ContribAuthor ">Alan P.  Venook</span>. </span><span class="cited-content_cbyCitation_article-title">Drug development in advanced colorectal cancer: Challenges and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Current Oncology Reports</span><span> <strong>2009,</strong> <em>11 </em>
                                    (3)
                                     , 175-185. <a href="https://doi.org/10.1007/s11912-009-0026-2" title="DOI URL">https://doi.org/10.1007/s11912-009-0026-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11912-009-0026-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11912-009-0026-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Oncology%2520Reports%26atitle%3DDrug%252Bdevelopment%252Bin%252Badvanced%252Bcolorectal%252Bcancer%25253A%252BChallenges%252Band%252Bopportunities%26aulast%3DKelley%26aufirst%3DRobin%2BK.%26date%3D2009%26date%3D2009%26volume%3D11%26issue%3D3%26spage%3D175%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew A.J.  Duncton</span>, <span class="hlFld-ContribAuthor ">Eugene L.  Piatnitski Chekler</span>, <span class="hlFld-ContribAuthor ">Reeti  Katoch-Rouse</span>, <span class="hlFld-ContribAuthor ">Dan  Sherman</span>, <span class="hlFld-ContribAuthor ">Wai C.  Wong</span>, <span class="hlFld-ContribAuthor ">Leon M.  Smith</span>, <span class="hlFld-ContribAuthor ">Joel K.  Kawakami</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Kiselyov</span>, <span class="hlFld-ContribAuthor ">Daniel L.  Milligan</span>, <span class="hlFld-ContribAuthor ">Chris  Balagtas</span>, <span class="hlFld-ContribAuthor ">Yaron R.  Hadari</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Sheetal N.  Patel</span>, <span class="hlFld-ContribAuthor ">Robin L.  Rolster</span>, <span class="hlFld-ContribAuthor ">James R.  Tonra</span>, <span class="hlFld-ContribAuthor ">David  Surguladze</span>, <span class="hlFld-ContribAuthor ">Stan  Mitelman</span>, <span class="hlFld-ContribAuthor ">Paul  Kussie</span>, <span class="hlFld-ContribAuthor ">Peter  Bohlen</span>, <span class="hlFld-ContribAuthor ">Jacqueline F.  Doody</span>. </span><span class="cited-content_cbyCitation_article-title">Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2009,</strong> <em>17 </em>
                                    (2)
                                     , 731-740. <a href="https://doi.org/10.1016/j.bmc.2008.11.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2008.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2008.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2008.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DArylphthalazines%252Bas%252Bpotent%25252C%252Band%252Borally%252Bbioavailable%252Binhibitors%252Bof%252BVEGFR-2%26aulast%3DDuncton%26aufirst%3DMatthew%2BA.J.%26date%3D2009%26volume%3D17%26issue%3D2%26spage%3D731%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Du</span>, <span class="hlFld-ContribAuthor ">Beilei  Lei</span>, <span class="hlFld-ContribAuthor ">Jin  Qin</span>, <span class="hlFld-ContribAuthor ">Huanxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors using QSAR and docking. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2009,</strong> <em>27 </em>
                                    (5)
                                     , 642-654. <a href="https://doi.org/10.1016/j.jmgm.2008.10.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2008.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2008.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2008.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DMolecular%252Bmodeling%252Bstudies%252Bof%252Bvascular%252Bendothelial%252Bgrowth%252Bfactor%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%252Busing%252BQSAR%252Band%252Bdocking%26aulast%3DDu%26aufirst%3DJuan%26date%3D2009%26volume%3D27%26issue%3D5%26spage%3D642%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V Craig  Jordan</span>, <span class="hlFld-ContribAuthor ">Roshani  Patel</span>, <span class="hlFld-ContribAuthor ">Joan S  Lewis-Wambi</span>, <span class="hlFld-ContribAuthor ">Ramona F  Swaby</span>. </span><span class="cited-content_cbyCitation_article-title">By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research</span><span> <strong>2008,</strong> <em>10 </em>
                                    (S4)
                                     <a href="https://doi.org/10.1186/bcr2176" title="DOI URL">https://doi.org/10.1186/bcr2176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/bcr2176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fbcr2176%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%26atitle%3DBy%252Blooking%252Bback%252Bwe%252Bcan%252Bsee%252Bthe%252Bway%252Bforward%25253A%252Benhancing%252Bthe%252Bgains%252Bachieved%252Bwith%252Bantihormone%252Btherapy%26aulast%3DJordan%26aufirst%3DV%2BCraig%26date%3D2008%26date%3D2008%26volume%3D10%26issue%3DS4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hung  Huynh</span>, <span class="hlFld-ContribAuthor ">Van Chanh  Ngo</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Mark  Ayers</span>, <span class="hlFld-ContribAuthor ">Khee Chee  Soo</span>, <span class="hlFld-ContribAuthor ">Heng Nung  Koong</span>, <span class="hlFld-ContribAuthor ">Choon Hua  Thng</span>, <span class="hlFld-ContribAuthor ">Hock Soo  Ong</span>, <span class="hlFld-ContribAuthor ">Alexander  Chung</span>, <span class="hlFld-ContribAuthor ">Pierce  Chow</span>, <span class="hlFld-ContribAuthor ">Pamela  Pollock</span>, <span class="hlFld-ContribAuthor ">Sara  Byron</span>, <span class="hlFld-ContribAuthor ">Evelyn  Tran</span>. </span><span class="cited-content_cbyCitation_article-title">Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2008,</strong> <em>14 </em>
                                    (19)
                                     , 6146-6153. <a href="https://doi.org/10.1158/1078-0432.CCR-08-0509" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-08-0509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-08-0509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-08-0509%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DBrivanib%252BAlaninate%25252C%252Ba%252BDual%252BInhibitor%252Bof%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252Band%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BTyrosine%252BKinases%25252C%252BInduces%252BGrowth%252BInhibition%252Bin%252BMouse%252BModels%252Bof%252BHuman%252BHepatocellular%252BCarcinoma%26aulast%3DHuynh%26aufirst%3DHung%26date%3D2008%26date%3D2008%26volume%3D14%26issue%3D19%26spage%3D6146%26epage%3D6153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Réjean  Ruel</span>, <span class="hlFld-ContribAuthor ">Carl  Thibeault</span>, <span class="hlFld-ContribAuthor ">Alexandre  L’Heureux</span>, <span class="hlFld-ContribAuthor ">Alain  Martel</span>, <span class="hlFld-ContribAuthor ">Zhen-Wei  Cai</span>, <span class="hlFld-ContribAuthor ">Donna  Wei</span>, <span class="hlFld-ContribAuthor ">Ligang  Qian</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Amrita  Kamath</span>, <span class="hlFld-ContribAuthor ">Punit  Marathe</span>, <span class="hlFld-ContribAuthor ">Yueping  Zhang</span>, <span class="hlFld-ContribAuthor ">George  Derbin</span>, <span class="hlFld-ContribAuthor ">Barri  Wautlet</span>, <span class="hlFld-ContribAuthor ">Steven  Mortillo</span>, <span class="hlFld-ContribAuthor ">Robert  Jeyaseelan</span>, <span class="hlFld-ContribAuthor ">Benjamin  Henley</span>, <span class="hlFld-ContribAuthor ">Ravindra  Tejwani</span>, <span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>, <span class="hlFld-ContribAuthor ">George L.  Trainor</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (9)
                                     , 2985-2989. <a href="https://doi.org/10.1016/j.bmcl.2008.03.057" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.03.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.03.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.03.057%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bpreclinical%252Bstudies%252Bof%252B5-isopropyl-6-%2525285-methyl-1%25252C3%25252C4-oxadiazol-2-yl%252529-N-%2525282-methyl-1H-pyrrolo%25255B2%25252C3-b%25255Dpyridin-5-yl%252529pyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-4-amine%252B%252528BMS-645737%252529%25252C%252Ban%252Bin%252Bvivo%252Bactive%252Bpotent%252BVEGFR-2%252Binhibitor%26aulast%3DRuel%26aufirst%3DR%25C3%25A9jean%26date%3D2008%26volume%3D18%26issue%3D9%26spage%3D2985%26epage%3D2989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gretchen M.  Schroeder</span>, <span class="hlFld-ContribAuthor ">Xiao-Tao  Chen</span>, <span class="hlFld-ContribAuthor ">David K.  Williams</span>, <span class="hlFld-ContribAuthor ">David S.  Nirschl</span>, <span class="hlFld-ContribAuthor ">Zhen-Wei  Cai</span>, <span class="hlFld-ContribAuthor ">Donna  Wei</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Yongmi  An</span>, <span class="hlFld-ContribAuthor ">John  Sack</span>, <span class="hlFld-ContribAuthor ">Zhong  Chen</span>, <span class="hlFld-ContribAuthor ">Tram  Huynh</span>, <span class="hlFld-ContribAuthor ">Wayne  Vaccaro</span>, <span class="hlFld-ContribAuthor ">Michael  Poss</span>, <span class="hlFld-ContribAuthor ">Barri  Wautlet</span>, <span class="hlFld-ContribAuthor ">Johnni  Gullo-Brown</span>, <span class="hlFld-ContribAuthor ">Kristen  Kellar</span>, <span class="hlFld-ContribAuthor ">Veeraswamy  Manne</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Tai W.  Wong</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (6)
                                     , 1945-1951. <a href="https://doi.org/10.1016/j.bmcl.2008.01.121" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.01.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.01.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.01.121%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bpyrrolo%25255B2%25252C1-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine-based%252Binhibitors%252Bof%252BMet%252Bkinase%26aulast%3DSchroeder%26aufirst%3DGretchen%2BM.%26date%3D2008%26volume%3D18%26issue%3D6%26spage%3D1945%26epage%3D1951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig  Jamieson</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Moir</span>, <span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>, <span class="hlFld-ContribAuthor ">Grant  Wishart</span>. </span><span class="cited-content_cbyCitation_article-title">Strategy and Tactics for hERG Optimizations. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 423-455. <a href="https://doi.org/10.1002/9783527621460.ch18" title="DOI URL">https://doi.org/10.1002/9783527621460.ch18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527621460.ch18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527621460.ch18%26sid%3Dliteratum%253Aachs%26atitle%3DStrategy%252Band%252BTactics%252Bfor%252BhERG%252BOptimizations%26aulast%3DJamieson%26aufirst%3DCraig%26date%3D2008%26date%3D2008%26spage%3D423%26epage%3D455%26pub%3DWiley%26atitle%3DAntitargets%26aulast%3DVaz%26aufirst%3DRoy%2BJ.%26date%3D2008%26date%3D2008%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">T.  Constantieux</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems with One Bridgehead (Ring Junction) Nitrogen Atom: Two Extra Heteroatoms 0:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 629-644. <a href="https://doi.org/10.1016/B978-008044992-0.01014-2" title="DOI URL">https://doi.org/10.1016/B978-008044992-0.01014-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-008044992-0.01014-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-008044992-0.01014-2%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%252Bwith%252BOne%252BBridgehead%252B%252528Ring%252BJunction%252529%252BNitrogen%252BAtom%25253A%252BTwo%252BExtra%252BHeteroatoms%252B0%25253A2%26aulast%3DRodriguez%26aufirst%3DJ.%26date%3D2008%26spage%3D629%26epage%3D644%26pub%3DElsevier%26atitle%3DComprehensive%252BHeterocyclic%252BChemistry%252BIII%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erin T.  Pelkey</span>, <span class="hlFld-ContribAuthor ">Jonathon S.  Russel</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 5.2 Five-membered ring systems: pyrroles and benzo analogs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 135-175. <a href="https://doi.org/10.1016/S0959-6380(08)80008-6" title="DOI URL">https://doi.org/10.1016/S0959-6380(08)80008-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(08)80008-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2808%2980008-6%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B5.2%252BFive-membered%252Bring%252Bsystems%25253A%252Bpyrroles%252Band%252Bbenzo%252Banalogs%26aulast%3DPelkey%26aufirst%3DErin%2BT.%26date%3D2008%26spage%3D135%26epage%3D175%26pub%3DElsevier%26atitle%3DA%252Bcritical%252Breview%252Bof%252Bthe%252B2006%252Bliterature%252Bpreceded%252Bby%252Btwo%252Bchapters%252Bon%252Bcurrent%252Bheterocyclic%252Btopics%26date%3D2008%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pilar  Goya</span>, <span class="hlFld-ContribAuthor ">Cristina  Gómez de la Oliva</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 6.3 Triazines, tetrazines and fused ring polyaza systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 414-435. <a href="https://doi.org/10.1016/S0959-6380(08)80017-7" title="DOI URL">https://doi.org/10.1016/S0959-6380(08)80017-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(08)80017-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2808%2980017-7%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B6.3%252BTriazines%25252C%252Btetrazines%252Band%252Bfused%252Bring%252Bpolyaza%252Bsystems%26aulast%3DGoya%26aufirst%3DPilar%26date%3D2008%26spage%3D414%26epage%3D435%26pub%3DElsevier%26atitle%3DA%252Bcritical%252Breview%252Bof%252Bthe%252B2006%252Bliterature%252Bpreceded%252Bby%252Btwo%252Bchapters%252Bon%252Bcurrent%252Bheterocyclic%252Btopics%26date%3D2008%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilse  Zündorf</span>, <span class="hlFld-ContribAuthor ">Theo  Dingermann</span>. </span><span class="cited-content_cbyCitation_article-title">Angiogenese-Inhibitoren der Zukunft. Getreu dem Motto: Von der Versorgung abschnüren!. </span><span class="cited-content_cbyCitation_journal-name">Pharmazie in unserer Zeit</span><span> <strong>2007,</strong> <em>36 </em>
                                    (6)
                                     , 452-461. <a href="https://doi.org/10.1002/pauz.200700243" title="DOI URL">https://doi.org/10.1002/pauz.200700243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pauz.200700243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpauz.200700243%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmazie%2520in%2520unserer%2520Zeit%26atitle%3DAngiogenese-Inhibitoren%252Bder%252BZukunft.%252BGetreu%252Bdem%252BMotto%25253A%252BVon%252Bder%252BVersorgung%252Babschn%2525C3%2525BCren%252521%26aulast%3DZ%25C3%25BCndorf%26aufirst%3DIlse%26date%3D2007%26volume%3D36%26issue%3D6%26spage%3D452%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wolfram E  Samlowski</span>, <span class="hlFld-ContribAuthor ">Nicholas J  Vogelzang</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging drugs for the treatment of metastatic renal cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2007,</strong> <em>12 </em>
                                    (4)
                                     , 605-618. <a href="https://doi.org/10.1517/14728214.12.4.605" title="DOI URL">https://doi.org/10.1517/14728214.12.4.605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728214.12.4.605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728214.12.4.605%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DEmerging%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252Bmetastatic%252Brenal%252Bcancer%26aulast%3DSamlowski%26aufirst%3DWolfram%2BE%26date%3D2007%26date%3D2007%26volume%3D12%26issue%3D4%26spage%3D605%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Ayers</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Anne  Lewin</span>, <span class="hlFld-ContribAuthor ">Qiuyan  Wu</span>, <span class="hlFld-ContribAuthor ">J. Suso  Platero</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Validation of Biomarkers that Respond to Treatment with Brivanib Alaninate, a Small-Molecule VEGFR-2/FGFR-1 Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2007,</strong> <em>67 </em>
                                    (14)
                                     , 6899-6906. <a href="https://doi.org/10.1158/0008-5472.CAN-06-4555" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-06-4555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-06-4555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-06-4555%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DDiscovery%252Band%252BValidation%252Bof%252BBiomarkers%252Bthat%252BRespond%252Bto%252BTreatment%252Bwith%252BBrivanib%252BAlaninate%25252C%252Ba%252BSmall-Molecule%252BVEGFR-2%25252FFGFR-1%252BAntagonist%26aulast%3DAyers%26aufirst%3DMark%26date%3D2007%26date%3D2007%26volume%3D67%26issue%3D14%26spage%3D6899%26epage%3D6906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijaykumar  Deore</span>, <span class="hlFld-ContribAuthor ">Manoj V.  Lohar</span>, <span class="hlFld-ContribAuthor ">Nilambari  Yewalkar</span>, <span class="hlFld-ContribAuthor ">Ramswaroop  Mundada</span>, <span class="hlFld-ContribAuthor ">Seema  Ranaware</span>, <span class="hlFld-ContribAuthor ">Sanjay  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of quinazoline containing novel monoaryl ethers at room temperature. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2007,</strong> <em>44 </em>
                                    (2)
                                     , 495-498. <a href="https://doi.org/10.1002/jhet.5570440238" title="DOI URL">https://doi.org/10.1002/jhet.5570440238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.5570440238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.5570440238%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DRegioselective%252Bsynthesis%252Bof%252Bquinazoline%252Bcontaining%252Bnovel%252Bmonoaryl%252Bethers%252Bat%252Broom%252Btemperature%26aulast%3DDeore%26aufirst%3DVijaykumar%26date%3D2007%26volume%3D44%26issue%3D2%26spage%3D495%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex  Kiselyov</span>, <span class="hlFld-ContribAuthor ">Konstantin V  Balakin</span>, <span class="hlFld-ContribAuthor ">Sergey E  Tkachenko</span>. </span><span class="cited-content_cbyCitation_article-title">VEGF/VEGFR signalling as a target for inhibiting angiogenesis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2007,</strong> <em>16 </em>
                                    (1)
                                     , 83-107. <a href="https://doi.org/10.1517/13543784.16.1.83" title="DOI URL">https://doi.org/10.1517/13543784.16.1.83</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.16.1.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.16.1.83%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DVEGF%25252FVEGFR%252Bsignalling%252Bas%252Ba%252Btarget%252Bfor%252Binhibiting%252Bangiogenesis%26aulast%3DKiselyov%26aufirst%3DAlex%26date%3D2007%26date%3D2006%26volume%3D16%26issue%3D1%26spage%3D83%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia  Baka</span>, <span class="hlFld-ContribAuthor ">Andrew R  Clamp</span>, <span class="hlFld-ContribAuthor ">Gordon C  Jayson</span>. </span><span class="cited-content_cbyCitation_article-title">A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2006,</strong> <em>10 </em>
                                    (6)
                                     , 867-876. <a href="https://doi.org/10.1517/14728222.10.6.867" title="DOI URL">https://doi.org/10.1517/14728222.10.6.867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.10.6.867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.10.6.867%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DA%252Breview%252Bof%252Bthe%252Blatest%252Bclinical%252Bcompounds%252Bto%252Binhibit%252BVEGF%252Bin%252Bpathological%252Bangiogenesis%26aulast%3DBaka%26aufirst%3DSofia%26date%3D2006%26date%3D2006%26volume%3D10%26issue%3D6%26spage%3D867%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106dn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106dn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm051106d&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm051106dh00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106dh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106dh00001.jpeg" id="rightTab-_i7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  Synthesis of <b>12</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and reaction conditions:  (a) benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, 70 °C; (b) 1 N HCl, 80 °C, 64%, two steps; (c) POCl<sub>3</sub>, 110 °C; (d) DMF, NaH, 76%, two steps; (e) 10% Pd/C, HCOONH<sub>4</sub>, DMF, 86%; (f) (<i>R</i>)-(+)-propylene oxide, Et<sub>3</sub>N, EtOH, 70 °C, 53%.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106dh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm051106d&amp;id=jm051106dh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm051106df00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106df00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106df00001.jpeg" id="rightTab-_i9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 In vivo antitumor activity of <b>12</b> versus H3396 xenografts in athymic mice with dosing once a day for 10 days from day 14 to day 23 postimplant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106df00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm051106d&amp;id=jm051106df00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm051106df00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/medium/jm051106df00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106df00002.jpeg" id="rightTab-_i11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Structure of <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-7/jm051106d/production/images/large/jm051106df00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm051106d&amp;id=jm051106df00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"></div><p class="rightTab-references-count">
            This article references 11 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm051106db00001"><div class="reference"><strong class="refLabel"><a href="#jm051106db00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm051106db00001_1"><span><span class="NLM_string-ref">(a) Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. <i>  Nat. Med</i>. <b>1995</b>, <i>1</i>, 27−31.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=31&author=J+Folkman&title=Angiogenesis+in+cancer%2C+vascular%2C+rheumatoid+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DAngiogenesis%2520in%2520cancer%252C%2520vascular%252C%2520rheumatoid%2520and%2520other%2520diseases%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm051106db00001_2"><span><span class="NLM_string-ref">(b) Carmeliet, P.; Jain, R. K. Angiogenesis in cancer and other diseases. <i>  Nature</i><b>2000</b>, <i>407</i>, 249−257.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=257&author=P.+Carmeliet&author=R.+K+Jain&title=Angiogenesis+in+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00001_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00002"><div class="reference"><strong class="refLabel"><a href="#jm051106db00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm051106db00002_1"><span><span class="NLM_string-ref">Traxler, P. Tyrosine kinases as targets in cancer therapy − successes and failures. <i>  Exp. Opin. Ther. Targets</i><b>2003</b>, <i>7</i>, 215.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=215&author=P+Traxler&title=Tyrosine+kinases+as+targets+in+cancer+therapy+%E2%88%92+successes+and+failures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520in%2520cancer%2520therapy%2520%25E2%2588%2592%2520successes%2520and%2520failures%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Targets%26date%3D2003%26volume%3D7%26spage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00003"><div class="reference"><strong class="refLabel"><a href="#jm051106db00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm051106db00003_1"><span><span class="NLM_string-ref">Shawver, L. K.; Lipson, K. E.; Fong, T. A. T.; McMahon, G.; Plowman, G. D.; Strawn, L. M. Receptor tyrosine kinases as targets for inhibition of angiogenesis. <i>  Drug Discovery Today</i><b>1997</b>, <i>2</i>, 50−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=63&author=L.+K.+Shawver&author=K.+E.+Lipson&author=T.+A.+T.+Fong&author=G.+McMahon&author=G.+D.+Plowman&author=L.+M+Strawn&title=Receptor+tyrosine+kinases+as+targets+for+inhibition+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShawver%26aufirst%3DL.%2BK.%26atitle%3DReceptor%2520tyrosine%2520kinases%2520as%2520targets%2520for%2520inhibition%2520of%2520angiogenesis%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1997%26volume%3D2%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00004"><div class="reference"><strong class="refLabel"><a href="#jm051106db00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm051106db00004_1"><span><span class="NLM_string-ref">Ferrara, N.; Gerber, H. P.; Lecouter, J. <i>  Nat. Med</i>. <b>2003</b>, <i>9</i>, 669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=jm051106db00004/jm051106db00004_1&amp;dbid=16&amp;doi=10.1021%2Fjm051106d&amp;key=10.1038%2Fnm0603-669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=jm051106db00004/jm051106db00004_1&amp;dbid=8&amp;doi=10.1021%2Fjm051106d&amp;key=12778165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=jm051106db00004/jm051106db00004_1&amp;dbid=32&amp;doi=10.1021%2Fjm051106d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Ferrara%2C+N.%3B+Gerber%2C+H.+P.%3B+Lecouter%2C+J.+Nat.+Med.+2003%2C+9%2C+669+Ferrara%2C+N.%3B+Gerber%2C+H.+P.%3B+Lecouter%2C+J.+Nat.+Med.+2003%2C+9%2C+669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_jm051106db00004_1R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of VEGF and its receptors</span></div><div class="casAuthors">Ferrara, Napoleone; Gerber, Hans-Peter; LeCouter, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">669-676</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Vascular endothelial growth factor (VEGF) is a key regulator of physiol. angiogenesis during embryogenesis, skeletal growth and reproductive functions.  VEGF has also been implicated in pathol. angiogenesis assocd. with tumors, intraocular neovascular disorders and other conditions.  The biol. effects of VEGF are mediated by two receptor tyrosine kinases (RTKs), VEGFR-1 and VEGFR-2, which differ considerably in signaling properties.  Non-signaling co-receptors also modulate VEGF RTK signaling.  Currently, several VEGF inhibitors are undergoing clin. testing in several malignancies.  VEGF inhibition is also being tested as a strategy for the prevention of angiogenesis, vascular leakage and visual loss in age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp73RlVV-BkrVg90H21EOLACvtfcHk0li1bKkQti7W1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOnur4%253D&md5=7b3bc5510c26c80d75679920fbcb378e</span></div><a href="/servlet/linkout?suffix=jm051106db00004_1&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-669%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00005"><div class="reference"><strong class="refLabel"><a href="#jm051106db00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm051106db00005_1"><span><span class="NLM_string-ref">(a) Sepp-Lorenzino, L.; Thomas, K. A. Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development. <i>  Exp. Opin. Investig. Drugs</i><b>2002</b>, <i>11</i>, 1447−1465.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1465&author=L.+Sepp-Lorenzino&author=K.+A+Thomas&title=Antiangiogenic+agents+targeting+vascular+endothelial+growth+factor+and+its+receptors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26atitle%3DAntiangiogenic%2520agents%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520its%2520receptors%2520in%2520clinical%2520development%26jtitle%3DExp.%2520Opin.%2520Investig.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm051106db00005_2"><span><span class="NLM_string-ref">(b) Bilodeau, M. T.; Fraley, M. E.; Hartman, G. D. Kinase insert domain-containing receptor kinase inhibitors as anti-angiogenic agents. <i>  Exp. Opin. Invest. Drugs</i><b>2002</b>, <i>11</i>, 737−745.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=745&author=M.+T.+Bilodeau&author=M.+E.+Fraley&author=G.+D+Hartman&title=Kinase+insert+domain-containing+receptor+kinase+inhibitors+as+anti-angiogenic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00005_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DKinase%2520insert%2520domain-containing%2520receptor%2520kinase%2520inhibitors%2520as%2520anti-angiogenic%2520agents%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm051106db00005_3"><span><span class="NLM_string-ref">(c) Underiner, T. L.; Ruggeri, B.; Gingrich, D. E. Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. <i>  Curr. Med. Chem.</i><b>2004</b>, <i>11</i>, 731−745.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=745&author=T.+L.+Underiner&author=B.+Ruggeri&author=D.+E+Gingrich&title=Development+of+vascular+endothelial+growth+factor+receptor+%28VEGFR%29+kinase+inhibitors+as+anti-angiogenic+agents+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00005_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26atitle%3DDevelopment%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528VEGFR%2529%2520kinase%2520inhibitors%2520as%2520anti-angiogenic%2520agents%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00006"><div class="reference"><strong class="refLabel"><a href="#jm051106db00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm051106db00006_1"><span><span class="NLM_string-ref">Hurwitz, H.; Fehrenbacher, L.; Novotny, W.; Cartwright, T.; Hainsworth, J.; Heim, W.; Berlin, J.; Baron, A.; Griffing, S.; Holmgren, E.; Ferrara, N.; Fyfe, G.; Rogers, B.; Ross, R.; Kabbinavar, F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. <i>  New Engl. J. Med.</i><b>2004</b>, <i>350</i>, 2335−2342.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2342&author=H.+Hurwitz&author=L.+Fehrenbacher&author=W.+Novotny&author=T.+Cartwright&author=J.+Hainsworth&author=W.+Heim&author=J.+Berlin&author=A.+Baron&author=S.+Griffing&author=E.+Holmgren&author=N.+Ferrara&author=G.+Fyfe&author=B.+Rogers&author=R.+Ross&author=F+Kabbinavar&title=Bevacizumab+plus+irinotecan%2C+fluorouracil%2C+and+leucovorin+for+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DH.%26atitle%3DBevacizumab%2520plus%2520irinotecan%252C%2520fluorouracil%252C%2520and%2520leucovorin%2520for%2520metastatic%2520colorectal%2520cancer%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00007"><div class="reference"><strong class="refLabel"><a href="#jm051106db00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm051106db00007_1"><span><span class="NLM_string-ref">(a) Wood, J. M.; Bold, G.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Frei, J.; Hofmann, F.; Mestan, J.; Mett, H.; O'Reilly, T.; Persohn, E.; Rösel, J.; Schnell, C.; Stover, D.; Theuer, A.; Towbin, H.; Wenger, F.; Woods-Cook, K.; Menrad, A.; Siemeister, G.; Schirner, M.; Thierauch, K.-H.; Schneider, M. R.; Drevs, J.; Martiny-Baron, G.; Totzke, F.; Marmé, D. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. <i>  Cancer Res. </i><b>2000</b>, <i>60</i>, 2178−2189.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=2189&author=J.+M.+Wood&author=G.+Bold&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=J.+Frei&author=F.+Hofmann&author=J.+Mestan&author=H.+Mett&author=T.+O%27Reilly&author=E.+Persohn&author=J.+R%C3%B6sel&author=C.+Schnell&author=D.+Stover&author=A.+Theuer&author=H.+Towbin&author=F.+Wenger&author=K.+Woods-Cook&author=A.+Menrad&author=G.+Siemeister&author=M.+Schirner&author=K.-H.+Thierauch&author=M.+R.+Schneider&author=J.+Drevs&author=G.+Martiny-Baron&author=F.+Totzke&author=D.+Marm%C3%A9&title=a+novel+and+potent+inhibitor+of+vascular+endothelial+growth+factor+receptor+tyrosine+kinases%2C+impairs+vascular+endothelial+growth+factor-induced+responses+and+tumor+growth+after+oral+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3Da%2520novel%2520and%2520potent%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinases%252C%2520impairs%2520vascular%2520endothelial%2520growth%2520factor-induced%2520responses%2520and%2520tumor%2520growth%2520after%2520oral%2520administration%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm051106db00007_2"><span><span class="NLM_string-ref">(b) Abrams, T. J.; Murray, L. J.; Pesenti, E.; Walker Holway, V.; Colombo, T.; Lee, L. B.; Cherrington, J. M.; Pryer, N. K. Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer. <i>  Mol. Cancer Ther.</i><b>2003</b>, <i>2</i>, 1011−1021.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=1021&author=T.+J.+Abrams&author=L.+J.+Murray&author=E.+Pesenti&author=V.+Walker+Holway&author=T.+Colombo&author=L.+B.+Lee&author=J.+M.+Cherrington&author=N.+K.+Pryer&author=+Preclinical&title=%E2%80%9Cstandard+of+care%E2%80%9D+therapeutic+agents+for+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbrams%26aufirst%3DT.%2BJ.%26atitle%3D%25E2%2580%259Cstandard%2520of%2520care%25E2%2580%259D%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm051106db00007_3"><span><span class="NLM_string-ref">(c) Hennequin, L. F.; Stokes, E. S. E.; Thomas, A. P.; Johnstone, C.; Plé, P. A.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Kendrew, J.; Curwen, J. O. Novel 4-anilinoquinazolines with C-7 basic side chains:  design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. <i>  J. Med. Chem.</i><b>2002</b>, <i>45</i>, 1300−1312.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1312&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=A.+P.+Thomas&author=C.+Johnstone&author=P.+A.+Pl%C3%A9&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+Kendrew&author=J.+O.+Curwen&author=+Novel&title=basic+side+chains%3A%E2%80%89+design+and+structure+activity+relationship+of+a+series+of+potent%2C+orally+active%2C+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3Dbasic%2520side%2520chains%253A%25E2%2580%2589%2520design%2520and%2520structure%2520activity%2520relationship%2520of%2520a%2520series%2520of%2520potent%252C%2520orally%2520active%252C%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm051106db00007_4"><span><span class="NLM_string-ref">(d) Beebe, J. S.; Jani, J. P.; Knauth, E.; Goodwin, P.; Higdon, C.; Rossi, A. M.; Emerson, E.; Finkelstein, M.; Floyd, E.; Harriman, S.; Atherton, J.; Hillerman, S.; Soderstrom, C.; Kou, K.; Gant, T.; Noe, M. C.; Foster, B.; Rastinejad, F.; Marx, M. A.; Schaeffer, T.; Whalen, P. M.; Roberts, W. G. Pharmacological characterizat ion of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 7301−7309.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7309&author=J.+S.+Beebe&author=J.+P.+Jani&author=E.+Knauth&author=P.+Goodwin&author=C.+Higdon&author=A.+M.+Rossi&author=E.+Emerson&author=M.+Finkelstein&author=E.+Floyd&author=S.+Harriman&author=J.+Atherton&author=S.+Hillerman&author=C.+Soderstrom&author=K.+Kou&author=T.+Gant&author=M.+C.+Noe&author=B.+Foster&author=F.+Rastinejad&author=M.+A.+Marx&author=T.+Schaeffer&author=P.+M.+Whalen&author=W.+G+Roberts&title=Pharmacological+characterizat+ion+of+CP-547%2C632%2C+a+novel+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitor+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DJ.%2BS.%26atitle%3DPharmacological%2520characterizat%2520ion%2520of%2520CP-547%252C632%252C%2520a%2520novel%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitor%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm051106db00007_5"><span><span class="NLM_string-ref">(e) Gingrich, D. E.; Reddy, D. R.; Iqbal, M. A.; Singh, J.; Aimone, L. D.; Angeles, T. S.; Albom, M.; Yang, S.; Ator, M. A.; Meyer, S. L.; Robinson, C.; Ruggeri, B. A.; Dionne, C. A.; Vaught, J. L.; Mallamo, J. P.; Hudkins, R. L. A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors:  structure−activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055. <i>  J. Med. Chem.</i><b>2003</b>, <i>46</i>, 5375−5388.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5388&author=D.+E.+Gingrich&author=D.+R.+Reddy&author=M.+A.+Iqbal&author=J.+Singh&author=L.+D.+Aimone&author=T.+S.+Angeles&author=M.+Albom&author=S.+Yang&author=M.+A.+Ator&author=S.+L.+Meyer&author=C.+Robinson&author=B.+A.+Ruggeri&author=C.+A.+Dionne&author=J.+L.+Vaught&author=J.+P.+Mallamo&author=R.+L+Hudkins&title=A+new+class+of+potent+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors%3A%E2%80%89+structure%E2%88%92activity+relationships+for+a+series+of+9-alkoxymethyl-12-%283-hydroxypropyl%29indeno%5B2%2C1-a%5Dpyrrolo%5B3%2C4-c%5Dcarbazole-5-ones+and+the+identification+of+CEP-5214+and+its+dimethylglycine+ester+prodrug+clinical+candidate+CEP-7055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520structure%25E2%2588%2592activity%2520relationships%2520for%2520a%2520series%2520of%25209-alkoxymethyl-12-%25283-hydroxypropyl%2529indeno%255B2%252C1-a%255Dpyrrolo%255B3%252C4-c%255Dcarbazole-5-ones%2520and%2520the%2520identification%2520of%2520CEP-5214%2520and%2520its%2520dimethylglycine%2520ester%2520prodrug%2520clinical%2520candidate%2520CEP-7055%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm051106db00007_6"><span><span class="NLM_string-ref">(f) Wedge, S. R.; Kendrew, J.; Hennequin, L. F.; Valentine, P. J.; Barry, S. T.; Brave, S. R.; Smith, N. R.; James, N. H.; Dukes, M.; Curwen, J. O.; Chester, R.; Jackson, J. A.; Boffey, S. J.; Kilburn, L. L.; Barnett, S.; Richmond, G. H. P.; Wadsworth, P. F.; Walker, M.; Bigley, A. L.; Taylor, S. T.; Cooper, L.; Beck, S.; Jurgensmeier, J. M.; Ogilvie, D. J. AZD2171:  A highly potent, orally bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the treatment of Cancer. <i>  Cancer </i><i>Res</i>. <b>2005</b>, <i>65</i>, 4389−4400.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4400&author=S.+R.+Wedge&author=J.+Kendrew&author=L.+F.+Hennequin&author=P.+J.+Valentine&author=S.+T.+Barry&author=S.+R.+Brave&author=N.+R.+Smith&author=N.+H.+James&author=M.+Dukes&author=J.+O.+Curwen&author=R.+Chester&author=J.+A.+Jackson&author=S.+J.+Boffey&author=L.+L.+Kilburn&author=S.+Barnett&author=G.+H.+P.+Richmond&author=P.+F.+Wadsworth&author=M.+Walker&author=A.+L.+Bigley&author=S.+T.+Taylor&author=L.+Cooper&author=S.+Beck&author=J.+M.+Jurgensmeier&author=D.+J.+Ogilvie&author=+Vascular+Endothelial+Growth+Factor&title=Inhibitor+for+the+treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00007_6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26atitle%3DInhibitor%2520for%2520the%2520treatment%2520of%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00008"><div class="reference"><strong class="refLabel"><a href="#jm051106db00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm051106db00008_1"><span><span class="NLM_string-ref">Borzilleri, R. M.; Fargnoli, J.; Fura, A.; Gerhardt, T.; Hunt, J. T.; Mortillo, S.; Qian, L.; Tokarski, J.; Vyas, V.; Wautlet, B.; Zheng, X.; Bhide, R. S. Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-<i>f</i>][1,2,4]triazine based VEGFR-2 kinase inhibitors. <i>  Bioorg. Med. Chem. Lett.</i><b>2005</b>, <i>15</i>, 1429.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1429&author=R.+M.+Borzilleri&author=J.+Fargnoli&author=A.+Fura&author=T.+Gerhardt&author=J.+T.+Hunt&author=S.+Mortillo&author=L.+Qian&author=J.+Tokarski&author=V.+Vyas&author=B.+Wautlet&author=X.+Zheng&author=R.+S+Bhide&title=Synthesis+and+SAR+of+4-%283-hydroxyphenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+based+VEGFR-2+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25283-hydroxyphenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520based%2520VEGFR-2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00009"><div class="reference"><strong class="refLabel"><a href="#jm051106db00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm051106db00009_1"><span><span class="NLM_string-ref">Borzilleri, R. M.; Zheng, X.; Qian, L.; Ellis, C.; Cai, Z.-W.; Wautlet, B.; Mortillo, S.; Jeyaseelan, R.; Kukral, D. W.; Fura, A.; Kamath, A.; Vyas, V.; Tokarski, J. S.; Barrish, J. C.; Hunt, J. T.; Lombardo, L. J.; Fargnoli, J.; Bhide, R. S. <i>  J. Med. Chem.</i><b>2005</b>, <i>48</i>, 3991−4008.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Borzilleri%2C+R.+M.%3B+Zheng%2C+X.%3B+Qian%2C+L.%3B+Ellis%2C+C.%3B+Cai%2C+Z.-W.%3B+Wautlet%2C+B.%3B+Mortillo%2C+S.%3B+Jeyaseelan%2C+R.%3B+Kukral%2C+D.+W.%3B+Fura%2C+A.%3B+Kamath%2C+A.%3B+Vyas%2C+V.%3B+Tokarski%2C+J.+S.%3B+Barrish%2C+J.+C.%3B+Hunt%2C+J.+T.%3B+Lombardo%2C+L.+J.%3B+Fargnoli%2C+J.%3B+Bhide%2C+R.+S.+J.+Med.+Chem.+2005%2C+48%2C+3991%E2%88%924008.+Borzilleri%2C+R.+M.%3B+Zheng%2C+X.%3B+Qian%2C+L.%3B+Ellis%2C+C.%3B+Cai%2C+Z.-W.%3B+Wautlet%2C+B.%3B+Mortillo%2C+S.%3B+Jeyaseelan%2C+R.%3B+Kukral%2C+D.+W.%3B+Fura%2C+A.%3B+Kamath%2C+A.%3B+Vyas%2C+V.%3B+Tokarski%2C+J.+S.%3B+Barrish%2C+J.+C.%3B+Hunt%2C+J.+T.%3B+Lombardo%2C+L.+J.%3B+Fargnoli%2C+J.%3B+Bhide%2C+R.+S.+J.+Med.+Chem.2005%2C+48%2C+3991%E2%88%924008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm051106db00010_1"><span><span class="NLM_string-ref">(a) Bhide, R. S.; Fan, J.; Parlanti, L.; Barbosa, S.; Qian, L.; Cai, Z.-W.; Gibson, F. S. Process for preparing certain pyrrolotriazine compounds. PCT Int. Appl. WO 2004009542.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=009542&author=R.+S.+Bhide&author=J.+Fan&author=L.+Parlanti&author=S.+Barbosa&author=L.+Qian&author=Z.-W.+Cai&author=F.+S+Gibson&title=Process+for+preparing+certain+pyrrolotriazine+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DProcess%2520for%2520preparing%2520certain%2520pyrrolotriazine%2520compounds%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2004%26spage%3D009542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm051106db00010_2"><span><span class="NLM_string-ref">(b) Hennequin, L.; Stokes, E.; McKerrecher, D. Quinazoline derivatives as angiogenesis inhibitors. PCT Int. Appl. WO 200047212.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=47212&author=L.+Hennequin&author=E.+Stokes&author=D+McKerrecher&title=Quinazoline+derivatives+as+angiogenesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%26atitle%3DQuinazoline%2520derivatives%2520as%2520angiogenesis%2520inhibitors%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2000%26spage%3D47212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm051106db00011"><div class="reference"><strong class="refLabel"><a href="#jm051106db00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm051106db00011_1"><span><span class="NLM_string-ref">For the assay conditions of in vitro kinase, cellular proliferation, metabolic stability, cytochrome P450, and pharmacokinetic parameters, see ref 9.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+For+the+assay+conditions+of+in+vitro+kinase%2C+cellular+proliferation%2C+metabolic+stability%2C+cytochrome+P450%2C+and+pharmacokinetic+parameters%2C+see+ref+9.+For+the+assay+conditions+of+in+vitro+kinase%2C+cellular+proliferation%2C+metabolic+stability%2C+cytochrome+P450%2C+and+pharmacokinetic+parameters%2C+see+ref+9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm051106db00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13"><a href="/doi/suppl/10.1021%2Fjm051106d">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Characterization data for compounds <b>1</b>−<b>16</b>. Full experimental details and the characterization data for compound <b>12</b>. This material is available free of charge on the web at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm051106d/suppl_file/jm051106dsi20060213_033827.pdf">jm051106dsi20060213_033827.pdf (78.4 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm051106d&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm051106d%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2006.49.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm051106d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                77KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667986fbbffe23e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
